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ABSTRACT 
Investigating novel cis-acting regulatory elements involved in the regulation 
of heat shock response in cardiomyocytes. 
Ischemic heart disease is a disease which is characterized by the reduced blood 
supply to the heart. According to WHO 2013, ischemic heart disease is one of the 
major causes of death globally. For this reason, it is imperative to search for 
methods whereby heart cells can be protected from cell death.  The upregulation 
of heat shock proteins (Hsps) is one of the major techniques which can be used to 
protect the heart cells from Hsps cell death and improve the tolerance to ischemic 
stresses in various models. The increased expression of Hsps during heat shock 
pre-conditioning is regulated by heat shock transcription factors (HSFs). HSFs 
orchestrate the initiation of gene expression by binding to sequence motifs, known 
as cis-acting regulatory elements (CAREs). Since gene expression is regulated at a 
transcriptional level, it is expected that functionally related genes (e.g. heat shock 
response genes) might also be regulated by the same transcription factors (TFs).  
In this study an in silico approach was performed to identify the promoter 
sequences of 50 known heat shock responsive genes using Genomatix Software. 
This software was also used to identify transcription factor binding sites that are 
statistically over represented in the promoter sequences of these genes. The use of 
the Electrophoretic Mobility Shift Assay was included to confirm that protein cell 
lysates of stressed cells contain proteins (TFs) that bind to this sequence 
(SP1F_KLFS_01). Luciferase promoter reporter assay were also used to 
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investigate the transcriptional activity of mutant promoter constructs in which the 
SP1F_KLFS_01 was mutated. 
SP1F_KLFS_01 is a ±25 base pair sequence that was identified in the promoter 
sequences of 19 heat shock responsive genes, including the well-known Hsp70 
and Hsp90. This sequence is a potential binding site for two TFs, Specificity 
Protein-1 and Krueppel like TFs. Consequently, the aim of this study is to identify 
CAREs that are statistically over-represented in the promoter regions of heat 
shock response genes.  
In conclusion, in vitro experiments of this study did not support the findings of the 
in silico experiments, therefore additional methods should be implemented to 
expand the investigation for the involvement of cis-acting regulatory elements in 
the regulation of heat shock proteins in cardiomyocytes, prior to heat shock. 
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CHAPTER 1: LITERATURE REVIEW 
1.1 Introduction 
Cardiovascular disease is a serious global public health dilemma. Globally, almost 
20% of deaths are due to cardiovascular diseases, primarily due to coronary artery 
disease and stroke (Thygesen et al., 2007). The five main manifestations of 
coronary heart disease include stable angina pectoris, unstable angina pectoris, 
heart failure, myocardial infarction (MI) and sudden death (Mendis et al., 2010). 
MI is the main manifestation of coronary heart disease (Mendis et al., 2010).   
MI, commonly known as a heart attack, is associated with cardiomyocyte (heart 
muscle cells) cell death as a result of prolonged ischemia. Ischemia results from 
rapid disruption of blood supply to the heart, causing cardiomyocytes to be 
deprived of oxygen and nutrients, and eventually causing the death of these cells 
(Sahelian, 2012). The disruption of the blood supply can result from blockage of 
the coronary artery (blood vessels which supply the heart tissue with oxygen-rich 
blood and nutrients) by atherosclerotic plaques or blood clots forming in the 
coronary artery (Beltrami et al., 1994). If blood flow to the heart tissue is not 
restored within 20 to 40 minutes after the blockage occurred, the cardiomyocytes 
will die (Thygesen et al., 2007). If cardiomyocytes continue to die for 
approximately 6 to 8 hours, this can be considered as a "complete" heart attack. 
The areas in the heart muscle where cardiomyocytes died is eventually replaced 
by scar tissue. The death of cardiomyocytes results from both necrosis and 
apoptosis (Mendis et al., 2010).  
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Six primary risk factors of MI have been identified in relation to the development 
of atherosclerotic coronary artery disease (Sahelian, 2012). These risk factors 
include, hypertension, diabetes mellitus, hyperlipidemia (elevated levels of blood 
cholesterol and triglycerides in the blood due to unhealthy food 
consumption), smoking, gender (generally males are more prone to suffer a MI), 
and familial history of atherosclerotic arterial disease (Nabel and Braunwald, 
2012; Sahelian, 2012).  
There are various treatments for MI. One of which is surgery; however there are 
limitations to this treatment method as there will be a chance of thrombosis, 
limited durability and the likelihood for further surgery in the future (Lange et al., 
2001). Tissue engineering and drug delivery approaches have been exploited in 
recent years as a treatment method for patients with MI. Approaches which 
effectively protected myocardial cells include stem cell therapy, cardiac TFs (Pu 
and Izumo, 2001) and heat shock proteins (Hsps) (Lee et al., 2009).  
The cytoprotective effects Hsps in cardiomyocytes have been demonstrated in 
several studies (Latchman, 2001). Mestril et al., demonstrated that the exposure of 
embryonal rat heart derived cells (H9c2 (2-1)) to non-lethal heat stress resulted in 
the increased expression of Hsps, specifically inducible Hsp70 isoforms leading to 
cytoprotection (Mestril et al., 1994). It was shown that cells stably overexpress 
the inducible form of Hsp70 protein, were much more resistant to ischemic-like 
stress, demonstrating that inducible Hsp70 plays a vital role in the protection of 
cardiac cells against ischemia. The heart was the first organ to present a protective 
effect with the over-expression of a single Hsp in intact animal models (Radford 
et al., 1996). A number of research groups used transgenic mice models to 
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demonstrate that the over-expression of Hsp70 protects the heart against the 
harmful effects of ischemia (Latchman, 2003). The employment of heat shock 
proteins to protect cardiomyocytes against cell death during cardiac stress such as 
ischemia is a viable therapeutic strategy for some cardiovascular disorders (Gill et 
al., 2006). 
 
1.2 Heat shock protein family 
Hsps (or stress proteins) are part of a protein family. The molecular weights of the 
proteins range from 8kDa to 150 kDa. Hsps are generally named according to 
their molecular weight, for example, the 70-kDa protein is referred to as Hsp70, 
and the encoding gene for this protein is hsp70 (Pagel, 2008). The expression of 
Hsps can be induced rapidly in response to stress stimuli through transcription and 
translation. Hsp gene transcription is regulated by HSFs (Boshoff et al., 2004). 
HSFs bind to heat shock elements within the promoter region of the heat shock 
gene and activate transcription of the heat shock gene (Hietakangas and Sistonen, 
2005).  
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1.2.1 Heat shock proteins as molecular chaperones 
The structure and function of a protein is dependent on its three-dimensional 
structure.  An unstable environment within the cell can affect this three- 
dimensional structure. The three-dimensional structure of proteins which are 
arranged into spirals, loops and sheets will begin to unravel in response to stress 
allowing the interior of these proteins to be exposed (Sanders, 1994).  Once the 
interior of proteins are exposed it may lead to adherence and globular formation 
of the protein causing the protein to become dysfunctional (Sanders, 1994).  
Hsps are vitally important as they are needed to ensure that newly synthesized 
polypeptides are correctly folded (Figure 1.1A) (Latchman, 2001). There are two 
groups of proteins in the heat shock family, namely, chaperones and 
cytoprotective proteins. Chaperones are constitutively expressed in the cell and 
play a vital role in the repair (or refolding) of denatured proteins, or promote the 
degradation of denatured or damaged proteins (Calderwood et al., 2006). The 
expression of these proteins is not affected by stressful stimuli (Vabulas et al., 
2010). Some well-known chaperone proteins include αB-crystallin, Hsp27, 
Hsp70, Hsp40, and Hsp90, as well as class I and class II chaperonins (Neef et al., 
2011). Table 1.1, lists some of the Hsps and the functional role they play in the 
cell.  
Hsps responsible for cytoprotectivity in the cell may be constitutively expressed, 
however, their expression is significantly upregulated in response to non-lethal 
stressful conditions (as shown in Figure 1.1B) (Concannon et al., 2003). This was 
demonstrated in studies where cells were pre-exposed to low levels of stress.  
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Figure 1.1: Heat shock proteins as molecular chaperones and as cytoprotective 
proteins in cells. A) Represents Hsps functioning as molecular chaperones, to aid 
in facilitating the correct folding and refolding of newly synthesized polypeptide 
chains which will assume its functional 3D protein configuration. B) Illustrates 
the ability of Hsps to repair denatured proteins. Upon a stressful insult, Hsps are 
expressed and assist in the refolding or degradation of the denatured protein 
(Whitley et al., 1999). 
 
 
 
 
  
 
 
 
A) 
B) 
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Table 1.1 Heat shock proteins and their various functions (Adapted from 
Latchman, 2001). 
 
 
 
For example, the transient exposure of cells to heat stress, also known as “heat 
shock preconditioning”, have been shown to lead to a heat shock response which 
cause the cells to be protected to subsequent stresses, such as hypoxia or ischemia 
(Whitley et al., 1999). Heat shock preconditioning was also shown to protect cells 
against heavy metal poisoning, arterial injury, heat or ischemic injury (Marber et 
al., 1993); and used in experimental models for cardiac ischemia, endotoxic 
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shock, arterial injury ethanol-induced gastric ulcerations and many more (Whitley 
et al., 1999). 
 
It has been observed that Hsps can prevent the demise of a cell by inhibiting 
specific points in the apoptotic pathway (FitzGerald et al., 2005).  
 
1.2.2 Heat shock proteins in disease 
Increased levels of stress proteins has been linked to a number of disorders, 
including, congestive heart failure, aging, atherosclerosis, neurodegenerative 
disorders, malignant diseases, and autoimmune disorders (Luo et al., 2010). 
Neurodegenerative disorders, such as Parkinson’s disease (PD), Alzheimer’s 
disease (AD), Huntington’s disease (HD) and various other polyglutamine 
expansion disorders are associated with the deregulation of apoptosis leading to 
the death of certain neuronal cell populations. When investigating the 
involvement of Hsps in the progression of diseases, such as cancer, the anti-
apoptotic properties of Hsps become relevant (Luo et al., 2010).    
 
Hsps provide a defence mechanism against misfolded proteins and mutated 
proteins, and therefore could respond in early stages of diseases with misfolding 
proteins. In patients with AD, HD and PD, early abnormalities in the axons can be 
partially reversed with the aid of Hsps (Wyttenbach
 
and Arrigo, 2000). It is known 
that Hsps are capable of interacting with toxic oligomeric precursors of protein 
deposits and also with misfolded or mutated conformations of monomers 
(Muchowski and Wacker, 2005). The mechanisms whereby Hsps improve and 
 
 
 
 
8 
 
protect neuronal cells are still poorly understood; therefore more research is 
needed to exploit the full therapeutic potential of Hsps during neurodegeneration. 
 
1.2.2.1 Parkinsons disease 
PD is a neurodegenerative disease which is characterized by the loss of dopamine-
producing neurons in the substantia nigra, a region in the midbrain responsible 
for eye movement, motor planning and addiction (Velíšková and Moshé, 2006). 
The common hallmark of PD is the formation of intracellular Lewy bodies, which 
are abnormal aggregates of misfolded α-synuclein protein that develops within 
neurons (Engelender, 2008). α-Synuclein is a presynaptic protein of unknown 
function which is mutated in PD and is the main component of Lewy body 
formation (Polymeropoulos et al., 1997). This suggests that abnormal protein 
homeostasis may be involved in the pathogenesis of the disease. Several studies 
suggest that the ubiquitin proteasomal system (UPS) and Hsps are implicated in 
PD (Luo et al., 2007). Ubiquitin molecules attach to damaged protein molecules 
and signal the degradation of ubiquitin-protein complexes via the protease, 26S 
proteasome (Samaii et al., 2004). Studies that identified mutations in α-synuclein, 
strongly suggests that the UPS will not be able to degrade these mutant forms of 
α-synuclein, leading to the accumulation of this protein (Engelender, 2008). 
Dedmon et al., demonstrated that Hsp70 could potentially inhibit α-synuclein 
fibril formation by binding to prefibrillar species, which will alter the toxic 
characteristics of α-synuclein aggregates (Dedmon et al., 2005). Therefore, this 
study demonstrated that Hsp70 had a beneficial role in the pathogenesis of PD, 
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and that the chaperone activity is a vital characteristic in protecting neuronal cells 
against the damaging effects of protein misfolding (Dedmon et al., 2005). 
The upregulation of Hsp70 and Hsp25 in response to prior heat shock protected 
PC12 cells (a cell line derived from a  neuroendocrine tumour of the rat adrenal 
medulla) against the neurotoxin 6-hydroxydopamine (6-OHDA) by lagging the 
release of cytochrome c, caspase activation and leading to a decreased level of 
apoptosis in cells exposed to 6-OHDA (Gorman et al., 2005). Therefore, it was 
noted that the induction of Hsp25 protected the cells from 6-OHDA-induced 
apoptosis.  6-OHDA is generally used to mimic PD effects and lead to the demise 
of dopaminergic neurons (Gill et al., 2006).  Zourlidou et al., also found Hsp27 to 
have protective properties against α-synuclein. It was shown that mammalian 
neuronal cells which over-express wild-type and the mutant forms (disease-
associated) of α-synuclein are protected from several death stimuli by the 
exogenous Hsp27, therefore presenting a neuroprotective role for Hsp27 against 
α-synuclein- induced neurotoxicity (Zoulidou et al., 2004). 
 
1.2.2.2 Alzheimer’s and Huntington disease 
In patients with Alzheimer’s disease, the accumulation of extracellular amyloid 
beta plaques, in the brain, has been noted (Ballard et al., 2011).  HD is a 
neurodegenerative disease caused by a CAG repeat expansion of the huntingtin 
(Htt) gene. HD destroys neuronal cells in the basal ganglia (part of the brain 
which controls movement, cognitive ability, and emotion) (Eidelberg and 
Surmeier, 2011). 
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The cytoprotective roles of Hsps in diseases such as HD and AD are not clearly 
defined as yet. However, it was noted that ethanol preconditioning (refers to a 
phenomenon whereby tissues are protected from the harmful effects of 
ischemia/reperfusion (I/R), by the prior ingestion of ethanol at very moderate 
levels) prevented amyloid beta-induced neurotoxicity as well as apoptosis in the 
hippocampal-entorhinal complex (situated in the brain) of neonatal rats 
(Belmadani et al., 2004). It was shown that ethanol preconditioning induces 
Hsp70 expression which protects neurons from the toxic effects of amyloid beta 
accumulation in AD. In HD models, it was shown that cells treated with 
extracellular Hsp70/Hsc70 protein, reduces poly-glutamine aggregation as well as 
apoptosis (Novoselova et al., 2005). This was done by using a purified 
Hsp70/Hsc70 sample from bovine muscle and using it in a model of HD. Once 
biotinylated Hsp70/Hsc70 was introduced to the cells a vast reduction (40-50%) 
in apoptotic cells was observed. It was then discovered that biotinylated 
Hsp70/Hsc70 co-localized alongside the polyglutamine inclusions, and when 
measuring the quantity and size of these inclusions, it was revealed that 
Hsp70/Hsc70 was capable of reducing both these parameters (Novoselova et al., 
2005). 
 
The overexpression of Hsps was also observed to have protective effects in both 
animal models and cell culture models of stroke. In a Hsp70 knockout experiment 
in mice it was shown that loss of hsp70.1 lead to an impaired apoptotic pathway 
characterised by the rapid release of cytochrome c into the cytoplasm and the 
activation of caspase 3 following focal cerebral ischemia (Gill et al., 2006). 
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Therefore, it can be deduced that the administration of Hsp70 to whole animal 
experiments, may have putative applications in the treatment of several diseases. 
 
1.2.2.3 Heat shock proteins in cardiovascular diseases  
Marber et al., showed that Hsp70 is induced by ischemia, and an inverse relation 
between the expression of Hsp70 induced by either ischemic or heat shock 
preconditioning and infarct size in animal models (Marber et al., 1993). 
Additionally, the increased expression of Hsp70 in response to simulated ischemia 
produces a cytoprotective effect in cultured cardiomyocytes (Mestril et al., 1994). 
The overexpression of Hsp70 in transgenic mice enabled the improved recovery 
of myocardial function, the preservation of metabolic recovery, and the reduction 
in infarct size following I/R (Latchman, 2001). Similar to Hsp70, 78-kDa glucose-
regulated protein (grp78) was also found to be upregulated during periods of 
ischemia. Studies revealed that the endoplasmic reticulum grp78 was rapidly 
upregulated during ischemic preconditioning (IP) (phenomenon whereby a tissue 
becomes resistant to sub lethal ischemic injury by prior exposure to brief periods 
of I/R) (Murry et al., 1986). This upregulation translated into cardio protection, as 
it was associated with a decrease in the number of necrotic cardiomyocytes in rat 
hearts, after coronary ligation (Shintani-Ishida et al., 2006).   
 
Hsp27 and αβ-crystallin have also been shown to protect primary cardiomyocytes 
against ischemia (Radford et al., 1996). The overexpression of Hsp27 and αβ-
crystallin, in cultured cardiomyocytes, has been shown to decrease the release of 
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creatine kinase. It is thought that Hsp27 and αβ-crystallin stabilizes the cell 
membrane through the involvement with the cytoskeleton (Martin et al., 1997). 
 
Though the mechanisms by which Hsps protect cardiomyocytes are poorly 
understood, it is thought that Hsps are capable of facilitating cardio protection via 
their biological function as molecular chaperones (Benjamin and McMillan, 
1998). For this reason it is suggested that Hsps are beneficial proteins which can 
be exploited in cardio protection.  
 
1.2.3 Advances in the therapeutic exploitation of Heat shock proteins 
Hsps are important regulators of apoptosis in cardiomyocytes. Hsps expressed in 
cardiomyocytes include, Hsp90, -70, -60, -27, and -10 (Hoefling, 2007). The 
induction of these proteins can occur in response to various agents, such as, 
cardiotrophin-1, heat shock, herbamycin A, and ethanol, conferring protection to 
the cardiomyocytes against stresses such as ischemia (Stephanou et al., 1998). 
Members of the Hsp70 and -27 families are the most widely studied and abundant 
groups of the myocardial Hsps, and the overexpression of these proteins can 
protect cells against apoptotic inducers such as serum withdrawal, ceramide, and 
lethal hypoxia (Sreedhar and Csermely, 2004). Some Hsps have been shown to be 
critical regulators of apoptosis in cardiomyocytes during exposure to stressful 
conditions, such as ischemia. However, the failure to induce the expression of 
these proteins during these stressful conditions may be a pathogenic factor in the 
development of cardiovascular diseases (Gill et al., 2002). The mechanism by 
which Hsps regulate the process of apoptosis is still poorly understood, however, 
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several studies on the mechanism of action of Hsp70 and Hsp27 are beginning to 
shed some insight on how Hsps control apoptosis (Brar et al., 1999). The 
overexpression of Hsp60 and Hsp10 has also been demonstrated to protect 
cardiomyocytes from I/R-induced apoptosis (Lin et al., 2001). These Hsps not 
only possess a cardioprotective effect in in vitro and animal studies, they also 
represent a potentially valuable treatment for cardiac disease (Radford et al., 
1996).  
Increasing the expression of Hsps, by ischemia, heat stress or various chemical 
substances, are vital for the protection of the heart. Numerous approaches aiding 
in increasing the rate of physiological recovery after infarct stunning and 
ventricular dysfunction are becoming significant goals in the management of 
acute MI (Benjamin and McMillan, 1998). Using tissue or whole body 
hyperthermia strategies to increase the expression of Hsps can be very difficult 
and extremely unrealistic in conscious humans. For this reason, pharmacological 
strategies have been implemented to increase the expression of stress proteins for 
cytoprotection, therefore ensuring a potential advantage against ischemic damage 
to the heart (Benjamin and McMillan, 1998). A potential approach is the use of 
protease inhibitors, which increases the level of unfolded proteins within cells. 
Alternate approaches encompass the development of small molecules and 
peptides that simulate in vivo actions of chaperones with therapeutic benefits 
(Benjamin and McMillan, 1998). The cardioprotective effect of Hsp induction in 
in vitro and animal experiments can be a possible treatment for cardiac disorders 
(Gill et al., 2002). Gene therapy may also be an alternative strategy, for example, 
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specifically targeting heart cells without inducing functional cellular alterations 
related with stress induced Hsp-induction (Brar et al., 1999).  
 
1.3 Cell survival in response to stressful insults 
The ways in which cells respond to stress vary from the activation of pathways 
that promotes the survival of cells to the activation of programmed cell death 
which destroys injured cells. The cell’s primary response to a stressful stimulus is 
to defend itself against the stressful insult and recover from the effects of the 
harmful stimulus (Fulda et al., 2010). 
 
The type as well as the level of the insult depends greatly on the type of stress and 
how effectively the cell will respond to deal with these conditions. For instance, 
protective responses (such as the unfolded protein response or the heat shock 
response) facilitate an increase in chaperone protein activity and enable the 
enhancement of the protein folding capacity within the cell, therefore, stabilizing 
the stress and in turn, promoting cell survival (Tamatani et al., 2001). The 
adaptive capacity of a cell also primarily determines its fate, this means that, the 
level as well as the mode of stress depends on, various defence mechanisms and 
pro-survival strategies; however, if these mechanisms are ineffective, then the cell 
will signal for the activation of cell death programs to eradicate the injured cells 
(Hori et al., 2006). The mechanism by which the cell dies (apoptosis, necrosis, 
pyroptosis, or autophagic cell death) frequently relies on its ability to manage the 
conditions it is exposed to (Fulda et al., 2010). 
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1.4 Heat shock proteins and apoptosis  
There are generally two responses by which cell death can occur, namely, 
accidental death (necrosis) and instructional death (apoptosis) (Fadeel and 
Orrenius, 2005). Necrosis can be defined as a passive form of cell death which 
generally occurs under pathological conditions, resulting in the swift loss of ion-
flux control which leads to swelling and rupturing of the cell and its cellular 
contents (Fadeel and Orrenius, 2005). Apoptosis, on the other hand, is a 
controlled, energy-dependent form of cell death encompassing a complex network 
of signal transduction pathways in the initiation and execution phases (Krijnen et 
al., 2002). Typical traits of apoptosis are condensation of nuclear chromatin, 
membrane blebbing, changes to the cell membrane, cell shrinkage, formation of 
apoptotic bodies and nuclear fragmentation (Krijnen et al., 2002; FitzGerald et al., 
2005).   
 
Apoptosis can be activated in response to a variety of stimuli for example, 
cytokines, cytotoxic drugs and oxidative stress (Fadeel and Orrenius, 2005). 
These various stimuli prompts the activation or initiation of apoptosis, by 
activating one or more signal transduction pathways, which then in turn activates 
a conserved family of aspartic-acid specific cysteine proteases, known as caspases 
(Gill et al., 2006). Caspases (Cysteine aspartic acid-specific proteases) are 
inactive precursor zymogens which are constitutively expressed within cells, these 
zymogens can be activated in response to apoptotic stimuli by alterations in the 
three dimensional structure of the protein (Donepudi and Grütter, 2002). Once 
activated, these caspases orchestrate cell death by the cleavage of specific subsets 
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of cellular substrates, and this leads to distinctive biochemical and morphological 
changes coupled in apoptotic cells (FitzGerald et al., 2005). Caspases can be 
classified as initiator caspases (upon apoptotic stimuli the caspases will initiate 
disassembly) or effector caspases (caspases which take part in the dissembly 
process of the cell) (MacFarlane and Williams, 2004). 
 
1.4.1 Apoptotic pathways leading to the activation of caspase-3  
The activation process of caspases can lead to three major pathways in apoptosis, 
namely, the intrinsic pathway (Figure 1.2), the extrinsic pathway (Figure 1.3), and 
the Endoplasmic reticulum (ER) stress signalling pathway (Figure 1.4). These 
pathways all have a similar purpose, to initiate apoptosis and destroy the cell 
(FitzGerald et al., 2005; Gill et al., 2006). 
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Figure 1.2: The intrinsic apoptotic pathway (Fadeel and Orrenius, 2005). 
Pro-apoptotic proteins; BCL-2-associated X protein (Bax), BH3-interacting 
domain death agonist (Bid) and BCL-2 antagonist killer (Bak) aid in the release of 
mitochondrial factors which facilitates apoptosis (Saelens et al., 2004). 
Mitochondria play a vital role in the regulation of apoptosis. Mitochondrial 
damage can occur in various modes via cytotoxic agents, for example, agents 
causing oxidative stress, resulting in the permeabilisation of the outer 
mitochondrial membrane and this causes the release of pro-apoptotic proteins 
(cytochrome c, SMAC/Diablo, apoptosis inducing factor and pro-caspases) into 
the cytosol (Elmore, 2007). Once cytochrome c is released, it forms a complex 
with adaptor protein (APAF-1) and pro-caspase 9, and these proteins form the 
apoptosome complex (Li et al., 1997). Activated caspase 9 will be released from 
the complex and activate downstream caspases, such as caspases 3, 6, and 7. The 
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activation of pro-caspase 3 will result in apoptosis (Budihardjo et al., 1999; 
Fadeel and Orrenius, 2005).  
 
Figure 1.3: The extrinsic pathway in the apoptotic pathway (Gill et al., 2006). 
The extrinsic pathway or death receptor pathway is initiated by the binding of 
specific ligands to cell surface receptors (Elmore, 2007).  Fas/CD95 ligands will 
bind to the Fas receptor and tumour necrosis factor (TNF) ligand will bind to the 
TNF receptor (TNFR) (Adams, 2003). The Fas and TNF receptors contain a 
similar region of homology at the cytoplasmic face (68 amino acids) and this is 
known as the death domain (DD) (Adams, 2003).  The binding of the Fas ligand 
(FasL) to the Fas receptor, recruits an adapter protein Fas Associated Death 
domain (FADD) and the binding of TNF ligand to TNF receptor, recruits an 
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adapter protein (TNF receptor-associated death domain) TRADD (Wajant, 2002). 
FADD will then activate pro-caspase 8/10 with the aid of death effector domains 
(DED), and pro-caspase 8/10 will form a DISC (Death Inducing Signalling 
Complex) (Elmore, 2007). Oligmerization and activation of pro-caspase 8/10 will 
cleave Bid, resulting in the translocation of truncated BID (with caspase 8/10) to 
the mitochondria and setting off the intrinsic pathway (Kischkel et al., 1995). 
Additionally, caspase 8/10 can activate caspase 7/3, leading to apoptosis. Another 
method of activating apoptosis through the Fas receptor is by the binding of an 
alternative adapter protein (Daxx) to Apoptosis Signal-regulating Kinase 1 
(ASK1), which is a MAP kinase. This leads to the activation of the c-Jun-N-
terminal kinase (JNK) pathway and this pathway activates apoptosis (FitzGerald 
et al., 2005). Also, TNF is capable of inhibiting the pro-survival signals of  
nuclear factor-κB (NFҡB) by the recruitment and activation of receptor interacting 
protein (RIP), NFҡB inducing kinase (NIK) and inhibitor of ҡB kinase complex 
(IKK), resulting in TNF-induced apoptosis (Malinin et al., 1997). 
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Figure 1.4: The ER stress signalling apoptotic pathway (Gill et al., 2006). 
The ER stress signalling pathway was discovered as a third mechanism for the 
activation caspases and the regulation of apoptosis (Nakagawa and Yuan, 2000). 
The ER is an important part of this pathway. It is known that post-translational 
modifications, protein folding, calcium storage and homeostasis all takes place in 
the lumen of the ER. Once the calcium homeostasis is interrupted, it can cause the 
accumulation of misfolded proteins (which is the case in diseases such as stroke 
and diabetes) and in turn activate the ER stress pathway (Nakagawa et al., 2000). 
Figure 1.4 shows the activation of apoptosis through the ER stress signalling 
pathway. Once there is a disruption of cystolic calcium levels in the cell, calpain 
will be activated (Harriman et al., 2002). The activation of calpain, results in the 
activation of Bid, which translocates to the mitochondria where it will trigger the 
intrinsic apoptotic pathway. On the other hand, calpain can activate pro-caspase 
12 resulting in the activation of downstream caspases and eventually the 
activation of apoptosis (Rao et al., 2004). 
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1.4.2 The control of apoptosis by stress proteins 
Changes in the intracellular redox balance and the hasty production of reactive 
oxygen species can initiate the apoptotic pathway; this in turn results in alterations 
in the mitochondria and the release of pro-apoptotic factors (Sreedhar and 
Csermeley, 2004). A method of maintaining redox homeostasis and mitochondrial 
stability in the cell relies on Hsp70 and Hsp27. Figure 1.5 demonstrates how 
stress proteins can control the process of apoptosis. After its release from the 
mitochondria, Hsp27 can cleave cytochrome c, and pro-caspase 3, therefore 
preventing the formation of the apoptosome complex and eventually preventing 
the activation of downstream caspases and apoptosis.  Hsp70 has also been shown 
to inhibit apoptosome formation, in cell-free systems. Overexpression of Hsp70 
allows for the protection of cells from stress-induced apoptosis (upstream and 
downstream of the caspase cascade activation) (Garrido et al., 2001). 
Furthermore, Hsp70 and Hsp27, have the ability to inhibit apoptosis and thus 
increase the cells survival to a wide range of lethal stimuli. Aside from the 
caspase-dependent apoptosis, Hsp27 has the ability to interfere directly with 
death-receptor inducing signals (extrinsic pathway). This is achieved through 
phosphorylated Hsp27 dimers capable of interacting with and inhibiting Daxx, 
which is linked with the Fas receptor and Ask 1 and downstream JNK pathway 
which in turn prevents apoptosis (Charette et al., 2000). Charette et al, noted that 
no inhibition of Daxx was observed with an HSP27 phosphorylation mutant (only 
expressed as a oligomer) or when apoptosis was induced by the transfection of a 
Daxx mutant with a deleted HSP27 binding domain. 
 
 
 
 
22 
 
 
Figure 1.5: The interactions of Hsp27and Hsp70 in the apoptotic pathway 
(FitzGerald et al., 2005). 
 
1.5 Transcriptional regulation of heat shock proteins 
Cellular stress (increased temperature, mechanical damage and exposure to 
toxins) causes the interruption of various metabolic processes and cellular 
structures, resulting in the death of the cell when a critical threshold is surpassed 
(Welch, 1993).  Heat stress (temperatures above 42°C) as well as ischemia are 
able to cause a great deal of damage to the cytoskeleton, such as re-organization 
of the cytoplasmic network, disintegration of threadlike intermediate filament 
networks into bulky perinuclear aggregates, relocalizaton of actin-containing 
fibres, and interruption of microtubules and mitotic spindles (Welch et al., 1991). 
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Similar shared characteristics of heat stress and early reversible ischemic injury 
include mitochondrial swelling, loss of mitochondria, and uncoupling of oxidative 
phosphorylation (Neely and Grotyohann, 1984). 
 
In 1962, Ritossa observed a pattern of chromosomal puffs in Drosophila cells 
when exposed to heat stress (Hietakangas and Sistonen, 2005). It was later 
demonstrated that the formation of these puffs are associated with the increased 
expression of Hsps (Hietakangas and Sistonen, 2005). Subsequent studies showed 
that numerous stress stimuli, for example heat stress, oxidative stress, exposure to 
protease inhibitors and heavy metals, can trigger the increased expression of Hsps 
(Ruis and Schüller, 1995). This increased expression of Hsps in response to stress 
stimuli is called the heat shock response. It is also an important physiological 
defence mechanism for the protection of cells from various harmful stimuli (Lee 
and Goldberg, 1998).  
The expression of Hsps during the heat shock response is regulated by a set of 
HSFs. These TFs control the transcription of various heat shock genes which may 
protect the cellular proteins against harmful environmental stresses (Trinklein et 
al., 2003). The mammalian HSF family contains four members, namely HSF 1, 
HSF 2, HSF 3 and HSF 4 (Rabindran et al., 1991). Two of these mammalian TFs, 
HSF 1 and HSF 2, play a role in interacting with particular sites in the promoter 
region of heat shock-induced genes during stressful or differentiation conditions, 
resulting in an increase in the transcriptional activity in these genes (Trinklein et 
al., 2003). 
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The activation of the heat shock response involves the trimerization and 
translocation of HSF1 from the cytosol to the nucleus in response to stressful 
stimuli (most commonly elevated temperatures) (Holmberg et al., 2001). When in 
the nucleus, HSF1 attaches to heat shock elements (found in the TATA-box-
proximal 5´-flanking regions of heat shock inducible genes) in promoter region of 
heat shock genes (Figure 1.6). Once the trimer binds to the heat shock element in 
promoter region of the Hsp gene it will result in the production of heat shock 
protein messenger RNA (mRNA) and several post-translational regulatory 
modiﬁcations of the protein will occur (Whitley et al., 1999). Eventually the 
mRNA will move to the cytosol where successive translation and production of 
heat shock proteins will occur (Figure 1.6) (Whitley et al., 1999). 
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Figure 1.6: The expression of the heat shock protein (Whitley et al., 1999). 
However, in an unstimulated state, HSF1 will remain inactive and in the 
monomeric form. The heat shock response will therefore not be activated. The 
initiation, execution and termination of the heat shock response is therefore tightly 
regulated, through post-translational modiﬁcations and protein interactions 
(Trinklein et al., 2003). 
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1.6 Transcriptional regulation of gene expression by transcription factors  
TFs are regulatory proteins which are involved in regulating gene expression 
(Zaret and Carroll, 2011). The DNA-binding domains of TFs have a 10
6
 fold 
higher affinity for their target sequences than the rest of the DNA strand, and 
these highly conserved sequences are used to classify TFs into “families”, for 
example, SOX proteins (TFs which bind to minor grooves in DNA), MADS box-
containing proteins (TFs which bind to the motif CC[A/T]GG also known as the 
CAG-box sequences) and POU factors (TFs containing a bipartite DNA binding 
domain) (Remenyi et al., 2004, Phillips, 2008). TFs also have the ability to 
function in groups or complexes, and form numerous interactions which will 
enable the binding of RNA polymerase to the complex and activate the 
transcription process (Phillips, 2008). In eukaryotes, genes are normally turned 
"off", therefore, TFs function to turn gene expression "on" (Garrett and Grisham, 
2005). However, in bacteria, the genes are expressed constitutively until TF turns 
it "off". TFs operate by recognizing specific nucleotide sequences (motifs), which 
are situated before or after the gene on the chromosome (up or downstream) 
(Phillips, 2008).  
Eukaryotic genes consist of promoter regions situated upstream of the gene, or 
enhancer regions which are situated up- or downstream of the gene, additionally 
eukaryotic genes contain certain motifs which can be recognized by several TFs 
(Garrett and Grisham, 2005). 
The mechanism by which TFs regulate gene expression is of vital importance in 
the functioning of a gene. TFs will bind to either enhancer or promoter regions of 
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DNA. The transcription of the adjacent gene will then be up- or down-regulated. 
Mechanisms by which gene expression can be regulated via TFs include, stabilize 
or inhibiting the binding of RNA polymerase to the DNA sequence, acetylation or 
deacetylation of specific histone proteins, histone acetyltransferase activity 
(acetylates histone proteins, weakening DNA to Histone binding and accessing 
DNA to transcription, the employment of co-activator or co-repressor proteins to 
the DNA transcription factor complex (Srinivas and Swamynathan, 1996; Garrett 
and Grisham, 2005). 
 
Research has shown that there is a uniform manner in which different organisms, 
respond to the same stressful stimulus. This process involves shutting off the 
general transcription mechanism and activating the transcription of a specific set 
of genes encoding Hsps or stress proteins. The stress proteins aid in maintaining 
correct protein conformation and prevent misfolding, as explained in section 3 
(Srinivas and Swamynathan, 1996). The induction of heat shock proteins in 
response to stressful stimuli (such as increased temperatures or ischemia) can be 
facilitated by the heat shock transcription factor (HSF-1) which binds to heat 
shock elements (HSEs). 
 
1.6.1 Regulation of the heat shock response by promoters of heat shock genes 
The heat shock response mechanism is known to be highly regulated at the level 
of transcription; however, there are some cases where translational regulation will 
take place (Ananthan et al. 1986). The heat shock response mechanism is 
 
 
 
 
28 
 
generated through conserved cis-acting regulatory promoter elements (or HSEs) 
found in the TATA-box-proximal 5´-flanking regions of heat shock inducible 
genes (Morimoto, 1998).  Cis-acting sequences are regulatory sequences that form 
part of the gene in question, therefore these cis-acting sequences will only 
influence the expression of the gene that contains them (Morimoto, 1998).  
 
These sequences are mostly found upstream of the transcription start site, 
however, they can also be found further upstream, or even within the introns and 
exons of the gene, or on the 3' end of the gene. The presence of multiple HSEs 
within approximately one hundred base pairs has been shown to be a signature of 
the majority of eukaryotic heat shock inducible genes (Schöffl et al., 1998). 
 
Approximately all heat shock responsive promoters contain heat shock elements 
with a conserved 5 base pairs modular unit 5´-nGAAn-3´, and can be present in 
the promoters of Hsps as inverted repeats (Morimoto, 1998). Once a HSE is 
deleted from a promoter, the stress-response mechanism will automatically be 
tuned off or become non-responsive. However, if the HSE is engineered, they will 
convey stress inducibility to promoters (Pelham and Bienz, 1982). HSEs bind to 
trans-active HSF (under stressful conditions) to induce the expression of heat 
shock responsive genes. Efficient binding of HSF to HSE involves at least three 
units, this essentially means the following sequence must be present, 5´-
nGAAnnTTCnnGAAn- 3´. It has been shown that in the HSF1 from the 
Arabidopsis plant is capable of binding consensus tripartite HSE sequences and 
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HSE-containing regions of the D. melanogaster HSP70 promoter (Hübel and 
Schöffl, 1994). 
 
 
 
Figure 1.7: The general structure and regulatory features of HSFs (adapted from 
Morimoto, 1998). A) Demonstrates the structural motifs of HSF1, as well as the 
DNA-binding domain, hydrophobic heptad repeats (HR-A/B and HR-C), the 
carboxy-terminal transcription activation domain, and the negative regulatory 
domains which eventually influence the activity of HSF1. Amino acid residues 
also indicate the various positions of these domains in HSF1 (Morimoto, 1998). 
B) Illustrates the intramolecular negatively regulated monomer, which can be 
activated upon stressful stimuli to form homotrimers with DNA-binding activity 
(Morimoto, 1998). 
 
In the binding of HSF to HSEs one mismatch of one nucleotide in the consensus 
sequence can be tolerated. The HSEs of all the heat shock promoters in 
Drosophila are shown to possess repeats of the dinucleotide GA (GA or CT) 
(Gilmour et al., 1989). The binding of a GAGA factor protein to these GA repeats 
A) 
B) 
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have been shown to be of vital importance in the process of ATP dependent 
nucleosome disruption in heat shock inducible promoters. This aids in the open 
configuration of promoters and allow for transcription activation (Tsukiyama et 
al., 1994; Srinivas and Swamynathan, 1996).  
 
1.6.2 In silico promoter analysis for the determination of conserved motifs 
The regulation of transcription is a very significant, and rate limiting step in gene 
expression. There are various types of cis-acting DNA sequence elements which 
play a role in contributing to this regulation, however, promoters are the easiest 
elements to locate as they are situated upstream of the transcription start sites. In 
earlier years, studies relating to functional studies of promoters were performed 
on a gene-by-gene basis and generating data sets as Eukaryotic Promoter 
Database (EPD), containing numerous human promoters (Trinklein et al., 2003). 
Recent attempts in identifying promoters on a large scale have also been 
endeavoured with computational approaches (Davuluri et al., 2001). Since the 
“draft” sequence of the human genome and the full-length cDNA sequence library 
are known, researchers speculate that strategies in identifying promoters would be 
to align full-cDNA sequences to human genome sequences, then predicting the 
transcription start sites (TSS), and identify sequences upstream from these sites. 
In this way the promoters will be identified as well as the sequence of interest. An 
example of this application was done by Suzuki and Sugano, who used an oligo-
capping approach enabling the enrichment of full-length cDNAs (Suzuki and 
Sugano, 2001). Suzuki and Sugano then proceeded to map these cDNAs onto 
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genomic sequences to predict the TSS, these TSS were then used to identify 
potential promoter regions of 1031 human genes (Trinklein et al., 2003).  
 
Promoter analysis software tools for the prediction of various binding sites 
include, Genomatix MatInspector, Genomatic ModelInspector, MATRIX 
SEARCH, Signal Scan. For this study, Promoter analysis was done with 
Genomatix software (Munich/Germany) (Werner et al., 2003).  
 
Modern developments in bioinformatics, with regard to promoter detection, now 
allows for the detection of promoters in megabase sequences. Promoter function is 
largely governed by the binding of TFs to their cognitive binding sites in promoter 
DNA sequences (Scherf et al., 2000). These binding sites act in a modular fashion 
to support protein complexes for transcriptional activation (Arnone and Davidson, 
1997). Modular organization of promoters will also be reflected in the DNA 
sequence by specific groups of transcription factor binding sites which represents 
functional modules within promoters, also known as promoter modules.  
Promoters of genes from similar gene classes often have different nucleotide 
sequences (Werner, 2001). Yet, co-expressed genes can still be identified because 
it is believed that they share promoter modules even if they belong to different 
gene classes (Werner, 1999). Furthermore, promoters of related genes will share a 
more common framework of TF binding sites. Therefore, it can be well 
established that genes which are expressed in the same tissue, will share a mutual 
organisation of regulatory binding elements. Thus, promoter motifs can represent 
“footprinting” of transcriptional regulatory mechanisms and provide valuable 
information about various signals and tissue specific control of expression in 
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novel genes. Also, analysing promoters for organizational features may provide 
important links between constant nucleotide sequences of a genome and vital 
characteristics of gene regulation and expression (Werner et al., 2003).  
 
 
Hypothesis 
The hypothesis of this study was that genes encoding proteins of the same group, 
for example heat shock responsive proteins, are related in a functional way, and 
that these genes are considered to share the same TFs and promoter motifs. 
Identifying these motifs will be beneficial in determining various characteristics 
of novel heat shock responsive genes on the basis of in silico techniques. This in 
turn, will provide information about the cytoprotective roles of genes and their 
various functions in certain pathways when exposed to stressful insults.  
 
Objectives 
The objectives of this study were to: 
a) Identify common promoter sequences of Hsps in Rattus norvegicus species. 
b) Identify shared cis-acting regulatory motifs in the promoter regions. 
c) Investigate in a molecular approach, if shared motifs are involved in the 
regulation of Hsps. 
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Aims  
The aims of this study were to find novel cis-acting regulatory sequences within 
the promoter sequences of Hsp70 promoters in cardiomyocytes (Rattus 
norvegicus species) when exposed to a non-lethal stress e.g. heat shock. This was 
done by using two experimental approaches, namely, In silico and molecular 
biology.  It is noted that conserved regions in these cis-acting regulatory 
sequences are an essential part for the regulation of Hsp70. Once Hsp70 is 
expressed in increased amounts, it could protect the cardiomyocytes from 
apoptosis. However, it is proposed that when mutating these conserved bases in 
the cis-acting regulatory sequences of Hsp70, it could turn off the regulation of 
Hsp70. In this study conserved regions were found and mutated, and following 
molecular experimental procedures, EMSA and Luciferase promoter reporter 
assay. Electrophoretic mobility shift assay was used to determine protein:DNA 
complexes, together with Promoter reporter assays to confirm that protein cell 
lysates of stressed cells contain proteins (transcription factors) that bind to the 
conserved sequence. These studies were done to evaluate the effects that these 
conserved regions have on the upregulation of Hsp70 in cardiomyocytes when 
exposed to heat shock, and in turn protect the cardiomyocyte from degradation 
(apoptosis). 
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CHAPTER 2: MATERIALS AND METHODS 
 
 2.1 Materials used and Suppliers  
Materials                                                                             Suppliers 
Acrylamide-BIS (37:5:1)     Bio-Rad 
Agarose                                            Whitehead Scientific  
Ammoniun persulphate (APS)    Promega 
Bovine serum albumin (BSA)     Roche 
Bromophenol blue                                                      Merck    
Coomassie Brilliant Blue R 250    Sigma-Aldrich 
Cytobuster ™ Protein Extraction Reagent   Novagen 
Dimethyl dicarbonate                                                  Sigma 
Dithiothreitol (DTT)       Roche 
Ethylene Diamine Tetra-acetic acid)  EDTA                    Sigma  
6X Gel Loading Buffer      Fermentas 
Glycerol                                                                    Merck 
Glycine        Merck 
Glacial acetic acid      Merck 
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Hybond- N
+ 
Positively charged nylon transfer membrane Amersham Pharmacia 
biotech 
Isoamyl alcohol       Merck 
Kanamycin       Roche 
Methanol        Merck  
Nuclease free water      Fermentas 
Penicillin        Sigma-Aldrich  
Ponceau S Stain      Sigma 
Puromycin       Life Technologies 
RNase A        Roche 
Sodium dodecyl sulphate (SDS)     Promega  
Sodium Chloride (NaCl)                                              Merck Chemicals  
Sodium hydroxide       Merck  
Sybr® Safe DNA Gel stain     Life Technologies 
Tris[hydroxymethyl] aminoethane (Tris)                         Merck 
Tryptone        Merck 
N, N, N΄, N΄-Tetra methylethylene-diamine (TEMED)  Sigma-Aldrich 
Yeast extract       Merck  
 
 
 
 
36 
 
2.2 Cell culture  
2X Trypsin-Versene® (EDTA)    Lonza  
Dimethyl sulphoxide (DMSO)     Sigma-Aldrich 
Dulbecco’s Modified Eagle medium (DMEM) GIBCO-Life 
Technologies  
Foetal Bovine Serum (FBS) GIBCO-Life 
Technologies 
Metafectene- PRO
TM
 Transfection Reagent                      Biontex Laboratories 
Phosphate buffered saline (PBS)     Lonza 
 
2.3 Kits used  
LightShift® Chemiluminescent EMSA kit   Thermo Scientific  
NucleoSpin® TriPrep kit      Macheret-Nagel 
Reverse Transcription System Kit                                 Promega 
Secrete-Pair ™ Dual Luminescence Assay Kit   GeneCopoeia 
Supersignal ® West Pico Chemiluminescent Subtrate Thermo Scientific 
Wizard ® Plus SV Minipreps DNA Purification  Promega 
system kit 
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2.4 Solutions and Buffers used 
2X Sample buffer: 100 mM Tris-HCl (pH 6.8), 25 % glycerol, 0.01 % BPB, 50 
mM DTT.  
6X Glycerol BPB Gel Loading Buffer: 30 % Glucose and 0.3 % Bromophenol 
blue. 
10X Running buffer: 25 mM Tris-HCl, 192 mM glycine, 0.1 % SDS. 
10X TE: 0.1 M Tris, 0.01 M EDTA. 
10X TBE: 0.9 M Tris, 0.89 M Boric Acid, 25 mM EDTA. 
Ammonium persulphate (APS): A 10 % stock solution was prepared in distilled 
water and stored at -20°C.  
Blocking solution: 5 % fat free milk powder dissolved in TBST. 
Bovine Serum Albumin (BSA): 3 % BSA dissolved in TBST and stored at 4°C. 
Coommassie staining solution: 0.02 % Coommassie Brilliant Blue R 250, 40 % 
methanol, 10 % acetic acid.  
Destaining solution: 10 % Methanol and 10 % Acetic acid.  
DEPC treated water: 0.1 % diethylpyrocarbonate dissolved in 2 litres of distilled 
water. Incubated at 22 °C overnight and autoclaved.  
Kanamycin: 100 mg/ml stock prepared in distilled water and stored at -20°C.  
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Luria agar: 10 g/l Tryptone, 5 g/l Yeast Extract Powder, 5 g/l NaCl, 14 g/l 
Bacteriological Agar. 
Luria Broth: 10 g/l Tryptone, 5 g/l Yeast Extract Powder, 5 g/l NaCl.  
Ponceau S staining solution: 0.1 % Ponceau S and 5 % Glatial acetic acid. 
Separating buffer: 1.5 M Tris-HCl, pH 8.8. 
Stacking buffer: 0.5 M Tris-HCl, pH 6.8.  
Sodium hydroxide/Sodium dodecyl sulphate (NaOH/SDS): 0.2 M NaOH and 1 
% SDS 
Transfer buffer: 25 mM Tris-HCl, 192 mM glycine, 20 % methanol. After 
preparation the buffer was kept at 4°C. 
TBST: 0.1 % Tween-20, 150 mM NaCl, 20 mM Tris. After the preparation the 
solution was kept at 4°C. 
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2.5 BIOINFORMATICS  
2.5.1 In silico analysis of heat shock responsive genes 
 
Figure 2.1 Strategy devised for in silico promoter analysis. 
A gene list of 50 well-known heat shock responsive proteins was generated using 
Genomatix software suite, Gene2Promoter (Genomatix, Germany). Using the 
search term “heat shock” (for Rattus norvegicus species), all genes that are heat 
shock responsive was identified. Subsequently, promoter sequences for these 
genes were identified, within these heat shock responsive proteins using 
Gene2Promoter. Only promoters which were experimentally verified were 
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considered. PromoterInspector was used to identify the experimentally verified 
promoters Promoters that were in silico predicted were excluded from the study.  
 
2.5.2 Identification common promoter motifs 
Common transcription factor binding sites were identified using MatInspector and 
ModelInspector was used to identify conserved promoter modules. CLUSTALW 
was used to identify highly conserved nucleotide sites in the promoter modules.  
 
2.6 PROMOTER REPORTER CONSTRUCTS  
2.6.1 Cloning vectors 
Two plasmid DNA vectors pEZX-pG04 and pEZX-pG04-Mut were acquired 
from Genecopeia™, USA. Both of these vectors are based on the GLuc-ON™ 
promoter reporter systems from Genecopeia™.  
 
2.6.2 pEZX-pG04 / GLuc-ON Promoter Reporter Clone  
The GLuc-ON™ promoter, from Genecopeia, is a dual-reporter system which 
uses GLuc as the promoter reporter and Secreted Alkaline Phosphatase (SEAP) as 
the internal control for signal normalization. The plasmid contains a Puromycin 
resistance gene, used in the selection of stable cell lines. The pEZX-pG04 plasmid 
contained the Hsp70 promoter sequence and can be used as a reporter for Hsp70 
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promoter activity. pEZX-pG04-Mut also contained Hsp70 promoter, but a 
mutation was introduced in the conserved region of the promoter module that is 
shared by heat shock responsive genes and was identified by in silico promoter 
analysis.  
 
Figure 2.2 Expression-ready pre-designed dual reporter pEZX-pG04 system 
created by Genecopoeia, representing the SEAP expression system as well as the 
GLuc-ON™ Promoter system. The dual GLuc-ON promoter reporter system 
contains the SEAP expression and the luciferase expression. SEAP is 
constitutively expressed in the plasmid and can be detected with the appropriate 
wavelength after the addition of a substrate. However, upon a stimulus (such as 
heat shock) the promoter will be activated and induce GLuc (luciferase), this can 
be measured with the appropriate wavelength after the addition of a substrate.  
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Figure 2.3 A circular map of the pEZX-pG04 Vector System, created by 
SnapGene Viewer. The map indicates the multiple cloning site for various 
restriction enzymes as well as antibiotic restsiance genes. Hsp70 promoter region 
(shown in red, in figure 2.3), located 6688 bp downstream of the Gaussia 
luciferase (Gau), contained the conserved promoter module SP1F_KLFS_01 (as 
shown in green, in figure 2.3). The pEZX-pG04-Mut contained point mutations 
within the SP1F_KLFS_01 sequence, located 1410 bp downstream of the 
transcription start site (TSS) of the Hsp70 promoter region. The pEZX-pG04 
contained no point mutations. Both constructs were generated by the 
Genecopeia™ company. 
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2.7 Transformation of Escherichia coli (E.coli) mc1061 cells.  
Bacterial strain E.coli mc1061 was used for all transformation procedures. 
Competent cells of the bacterial strain were kindly donated from Ms. C Kimar, 
(University of Stellenbosch, South Africa). The cells were thawed on ice and 100 
µl of the cells were added to 200-800 ng of the pEZX-pG04 plasmid DNA or 200-
800ng of pEZX-pG04-Mut plasmid DNA. The samples were incubated on ice for 
20 minutes. The cells were heat shocked at 42 °C for 1 minute and then incubated 
on ice for 5 minutes. Pre-warmed Luria broth (900 µl) was added and the tubes 
were incubated on a rotating wheel for 1 hour at 37 °C. After incubation 100 µl of 
culture was plated on Luria broth (LB) agar plates which contained 100 mg/ml 
kanamycin. The plates were incubated at 37 °C overnight. Colonies were selected 
and used to inoculate Luria broth containing 100 mg/ml kanamycin. The cultures 
were allowed to grow overnight at 37 °C.  
 
2.8 Storage of bacterial strains  
Glycerol stocks were prepared directly from overnight cultures, by adding 400μl 
80% sterile glycerol to 600μl of the overnight culture, which was then stored at -
80°C. 
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2.9 Plasmid DNA Isolation 
Plasmid DNA was isolated from bacterial cells with the Wizard ® Plus SV 
Minipreps DNA Purification system kit from Promega. 
2.9.1 Large-scale preparation and isolation of plasmid DNA 
 
A volume of 5 μl of the glycerol stock was streaked onto a LB agar plate (with 
appropriate antibiotic) and incubated at 37 °C overnight. This plate was then used 
for the isolation of plasmid DNA.  
Luria broth (100 ml) containing 100 mg/ml kanamycin was inoculated with a 
single colony of transformed E. coli and cultured overnight at 37°C with shaking.  
The culture (100 ml) was removed from the incubator and centrifuged at 3,000 x g 
for 15 minutes using a Beckman J2-21centrifuge. The supernatant was discarded. 
Plasmid isolation was carried out with the use of the SV MiniPreps DNA 
purification kit. Cell Resuspension Solution (300 µl) was used to resuspend the 
bacterial cell pellet, followed by the addition of Cell Lysis Solution (500 µl). The 
solution was inverted 4 times followed by the addition of Alkaline Protease 
Solution (20 µl). The solution was inverted 4 times, incubated at room 
temperature for 5 minutes. Neutralization solution (500 µl) was added to the 
solution and inverted 4 times to mix and centrifuged at 13, 500 x g for 10 minutes 
using the Eppendorf 5415D Benchtop Centrifuge. Columns and collection tubes 
were set up and the clear lysate was transferred to the column, left on the bench 
for 1 min and centrifuged at 12,000 x g for 1 minute. The flow through was 
discarded, and the column re-inserted into the collection tube. Wash Solution (750 
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µl) was added to the column and centrifuged at 12,000 x g for 1 minute. The flow 
through was discarded and the column re-inserted into the collection tube. Wash 
Solution (250 µl) was added to the column and centrifuged at 13, 500 x g for 1 
minute. The column was transferred to a sterile 1.5 ml centrifuge tube, 50 µl of 
nuclease-free water was added and the tube was left at room temperature for 1 
minute. The tube was centrifuged for 2 minutes at 13, 500 x g. The eluted DNA 
was stored at –20 °C. The plasmid DNA was quantified with the use of the 
NanoDrop ND-100 Spectrophotometer (NanoDrop Technologies). 
 
2.10 Agarose gel electrophoresis of plasmid DNA 
The plasmid DNA was electrophoresed on a 1 % agarose gel. The agarose was 
made by the addition of the appropriate amount of agarose and 1X TBE. The 
mixture was boiled until the agarose was dissolved. The mixture was cooled and 
Sybr Safe was added to a final concentration of 0.8X. The agarose was poured 
into gel casting trays and allowed to solidify. DNA was mixed with an appropriate 
amount of 6x gel loading buffer. The gels were electrophoresed at 100 V in 1X 
TBE electrophoresis buffer. After electrophoresis, the gels were viewed with the 
use of UV trans-illuminator. Gel images were captured with an image capturing 
system (ChemiDoc UVP System). 
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2.11 CELL CULTURE AND THE MAINTENANCE OF H9c2 CELLS 
2.11.1 Thawing of H9c2 cells 
H9c2 cells (kindly donated from Prof. Afshin Samali, National University of 
Ireland, Galway), derived from the rat heart, were used for the purpose of this 
study. The frozen vials of H9c2 cells were removed from the -150 °C freezer and 
thawed in a 37 °C water bath. The cells were transferred to a 15 ml tube which 
contained 3 ml Dulbecco’s modified Eagle’s medium (DMEM) supplemented 
with 10 % Foetal Bovine Serum (FBS) and 10 % penicillin and streptomycin 
(complete media). The latter was transferred into a 25 cm
2
 tissue culture flask. 
The flask was incubated at 37 °C in 5 % CO2 and media was changed every 48 
hours until 60 - 90 % confluency was reached. 
  
2.11.2 Trypsinization of cells 
The cells were trypsinized once confluency was reached. The DMEM media in 
the flask was discarded and cells were washed with phosphate buffered saline 
(PBS). The PBS was discarded and the cells were trypsinized with the addition of 
2 Χ trypsin-versene® (EDTA). The cells were incubated for 2 – 3 minutes at 37 
°C, 5 % CO2. DMEM media was added to the flask to stop trysinization. The cells 
were collected by centrifugation at 3 000 g. 
 
 
 
 
 
47 
 
2.11.3 Freezing of cells 
For long term storage the cells were trypsinized and centrifuged. The cell pellet 
was resuspended in DMEM media containing 10 % DMSO. The latter was 
aliquoted into 2 ml cryo-vials and stored at -150 °C. 
 
2.11.4 Maintenance of H9c2 cells 
H9c2 cells were cultured in a 25 cm
2
 flask and incubated at 37 °C, 5 % CO2, until 
60 – 90 % confluency was reached. DMEM media was decanted from the culture 
flask. The cells were washed with PBS and the PBS was decanted. Cells were 
trypsinized as described in section 2.11.2.  Cells were then counted with the use of 
the Countess automated cell counter (Invitrogen). Cells were seeded in a 6-well 
plate at a density of 1 x 10
6
 cells per well and allowed to grow till 50 – 60% 
confluency in a 37°C incubator with 5% CO2. 
 
2.11.5 Transfection of pEZX-pG04 and pEZX-pG04-Mut constructs into H9c2 
cells  
The pEZX-pG04 plasmid DNA and the pEZX-pG04-Mut plasmid DNA 
(transfection-ready clones) were prepared as described section 2.9.1. Four tubes 
were set up for the preparation of Metafectene
TM 
PRO (as shown in table 2.1). 
DNA concentrations of 2 μg were set up for pEZX-pG04 and pEZX-pG04-Mut 
plasmid DNA reactions.  
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Table 2.1 Contents of tubes used for the transfection of pEZX-pG04 wild type 
and mutant constructs into H9c2 cells. 
 
Tube Contents 
A  2 μg of pEZX-pG04 plasmid consisted of 2.7 μl of the 
plasmid DNA and 47.3 µl of DMEM media (serum-free) 
B 2 μg of pEZX-pG04-Mut plasmid consisted of 20 μl of the 
plasmid DNA and 30 µl of DMEM media (serum-free) 
C 6 µl Metafectene
TM
 PRO and 44 µl of DMEM media 
(serum free)  
D 6 µl Metafectene
TM
 PRO and 44 µl of DMEM media 
(serum free) 
 
Tubes A and C, and tubes B and D were mixed and incubated at room temperature 
for 20 minutes. 
H9c2 cells were seeded in 6 well culture plates the day before. An untransfected 
control was also included in the experiment. Media was decanted and the cells 
were washed with PBS. Serum-free DMEM media (1 ml) was added onto the 
cells, followed by the addition of the DNA/metafectene mixtures (tubes A and C, 
and tubes B and D) and the plate was gently swirled. The plate was placed in the 
incubator at 37 °C and 5% CO2 for 3 hours. The plate was swirled gently every 30 
min. After 3 hours, 1 ml complete DMEM media was added to the wells and 
incubated at 37 °C and 5% CO2. After 48 hours the cells were treated with 
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DMEM media which contained 1 µg/ ml of puromycin. The cells were maintained 
in this media for 3 weeks until the cells in the control (no DNA added) were all 
dead.   
 
2.12 Heat shock preconditioning assay 
H9c2 cells were cultured in cell culture flasks (either 6 cell well culture plates or 
25 cm
2
 flasks) till confluency was reached. Once confluent, fresh culture media 
was placed on the cells. The cells were heat shocked at 42°C for 1 hour and 
allowed to recover for 0, 1, 4, 6 and 24 hours at 37°C, 5% CO2. A non-heat 
shocked control was always included. 
 
2.13 Extraction of cellular proteins from H9c2 cells 
Total cellular proteins were isolated using Cytobuster™ Protein Extraction 
Reagent. Culture media was removed and the cells were washed once with PBS 
for 5 minutes on a shaker at room temperature. Once this was completed, the PBS 
was decanted and replaced with 500μl Cytobuster™ Protein Extraction Reagent. 
The flask was placed on a shaker at room temperature for 5 minutes. The cells 
were scraped off in the Cytobuster™ Protein Extraction Reagent, using a cell 
scraper. The extract was transferred into a 1.5ml sterile Eppendorf tube and 
centrifuged for 5 minutes at 16 000 x g. The supernatant contained the proteins 
and was transferred to a sterile 1.5ml Eppendorf tube. Extracted proteins were 
quantified using the Qubit® 2.0 Fluorometer by Invitrogen. The proteins were 
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separated on a 12 % protein gel (see section 2.15.1) at 120 V, and stained with 
coomassie (as described in section 2.14), and protein size as well as equal loading 
for Western blot analysis was determined. The protein lysates were stored at -20 
°C. 
 
2.14 Coomassie Staining and De-staining of polyacrylamide gels 
Gels were placed in Coomasie staining solution, and was allowed to shake gently 
overnight. Then it was de-stained using de-staining solution, for 2 hours with 
gentle shaking. After the bands were clearly visible, with exposure to white light, 
the de-staining solution was decanted and the gel was washed extensively with 
distilled water and stored in plastic wrap at room temperature, or imaged using the 
ChemiDoc UVP system.  
 
 2.15 Western Blot Analysis of Hsp70 expression 
2.15.1 Polyacrylamide gel electrophoresis separation of protein samples and 
Western Blotting 
Protein separation was achieved by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE). A 12 % SDS- polyacrylamide gel was prepared as 
follows: 
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Table 2.2 Materials used for the preparation of sodium dodecyl sulphate 
polyacrylamide gel  
Solutions 12% Separating gel 5% Stacking gel 
Distilled water 4.28 ml 2.67 ml 
40% Acrylamide (37:5:1)  3 ml 0.5 ml 
1.5 M Tris pH8.8 2.5 ml -  
0.5 M Tris pH6.8 -  0.63 ml 
0.05 ml  10 % sodium dodecyl 
sulphate (SDS) 
10 % Ammonium 
persulphate (APS) 
0.1 ml 
 
0.1 ml  
 
0.05 ml 
TEMED 0.02 ml 0.02 ml 
 
A 12 % separating gel was prepared (shown in table 2.2) and poured into a gel 
casting apparatus and covered with isopropanol to even out the gel. The gel was 
allowed to polymerize for approximately 20 minutes at room temperature. Once 
the gel has solidified, the isopropanol was poured off and washed extensively with 
distilled water to remove all traces of isopropanol. The stacking gel was then 
prepared as in table 2.2, and was poured on the separating gel, followed by the 
insertion of a 1 mm comb, and allowed to polymerise for approximately 20 
minutes at room temperature. Protein extracts (20 μg) were then mixed with an 
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appropriate amount of 2 x sample buffer and boiled at 95° C for 5 minutes. The 
protein samples were then centrifuged for 5 minutes at 13 200 x g, and 20 μl of 
sample was loaded onto a pre-electrophoresed 12 % polyacrylamide gel. Samples 
were electrophoresed until the bromophenol blue band was electrophoresed out of 
the separating gel which was approximately 60 min of applying a voltage of 120 
V in a Mini-Protean tetra cell chamber (BIO-RAD). After the proteins have been 
separated, it was transferred onto a polyvinylidene fluoride (PVDF) membrane 
and electroblotted in transfer buffer for 90 minutes in a 4°C cold room with 
continuous stirring to maintain a cooling temperature. For the confirmation of 
protein transfer to the membrane, the membrane was stained for 5 minutes in 
Ponceau S Staining solution and once confirmed, the stain was rinsed off with 
distilled water.  
Once protein transfer and confirmation process was completed the membrane was 
blocked in 5% fat-free milk powder dissolved in TBST for 60 minutes at room 
temperature.  
 
2.15.2 Primary and secondary probing with antibodies and detection 
After blocking the membrane, it was washed four times with TBST for 5 minutes 
each at room temperature with continuous shaking. The Hsp70 (3A3) (Santa Cruz 
Biotechnology Inc., Europe) primary antibody (diluted 1:500 in 3% BSA-TBST 
solution) was added onto the membrane and placed on a shaker overnight at 4°C. 
The membrane was washed 3 times with TBST for 5 minutes each, then incubated 
with a horse raddish peroxidase (HRP)-conjugated goat anti-mouse secondary 
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antibody (Santa Cruz Biotechnology Inc., Europe) diluted at 1:2000 in 3% BSA-
TBST solution, for 60 minutes at room temperature on a shaker. Following the 
incubation, the membrane was then washed three times in TBST, for 5 minutes 
each wash. The detection of the HRP conjugated antibodies on the membrane was 
done with the aid of the Supersignal® West Pico Chemiluminescent Subtrate 
(Thermo Scientific), and the membrane was imaged using the ChemiDoc UVP 
system.  
After detecting the expression patterns of Hsp70 on the membrane, in the protein 
lysates, the antibodies were stripped from the membrane by incubating the 
membrane in 0.2 M NaOH for 5 minutes at room temperature. The membrane was 
then washed in distilled water for 10 minutes on a shaker, and the membrane was 
blocked in 5% fat-free milk powder dissolved in TBST. The membrane was 
washed thrice in TBST, and incubated with β-Actin (C-2) mouse monoclonal 
antibody (Santa Cruz Biotechnology Inc., Europe) (diluted 1:1000 in 3% BSA-
TBST solution) overnight at 4°C. Following the primary antibody incubation, the 
membrane was washed three times with TBST for 5 minutes each and incubated 
with a HRP-conjugated goat antimouse secondary antibody for 60 minutes at 
room temperature.  The detection of the HRP conjugated antibodies on the 
membrane was done with the aid of the Supersignal® West Pico 
Chemiluminescent Subtrate (Thermo Scientific), as described above.  
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 2.16 Promoter Reporter assay 
H9c2 cells that were stably transfected with either pEZX-pG04 or pEZX-pG04-
Mut were cultured in 6 well cell culture plates. The cells were then heat shocked 
by incubating the culture plates at 42°C for 1 hour. Cells were then allowed to 
recover for various time periods (0, 1, 4, 6, and 24 hours) at 37°C, 5% CO2. For 
comparison studies in cytoprotection experiments, a non-heat shocked control was 
included. The cell culture medium was collected (100 μl) at the end of every 
recovery period and stored at -20°C.  
The Secrete-Pair ™ Dual Luminescence Assay Kit (supplied by GeneCopoeia) 
was used for the detection and analysis of secreted reporter proteins, Gaussia 
Luciferase (GLuc) and Secreted Alkaline Phosphatase (SEAP) activities, in a cell 
culture medium.  
 
2.16.1 Gaussia Luciferase Assay for high sensitivity using GL-H buffer 
A volume of 100 μl of cell culture medium of the relevant time period was placed 
at room temperature till completely thawed. Buffer GL-H (10 X) was thawed at 
room temperature, inverted a few times and vortexed for approximately 4 
seconds. Once the Buffer GL-H was thawed a 1 X solution was made. Once the 
GL-H buffer was prepared a GLuc assay working solution was prepared by 
adding 10 μl of Substrate GL to 1 ml of 1 X buffer GL-H. The solution was mixed 
well by inverting a few times, and incubated at room temperature in the dark for 
25 minutes. A volume of 10 μl of cell culture medium was added to a 96 well 
 
 
 
 
55 
 
black-base plate and 100 μl of the GLuc assay working solution was added to the 
cell culture medium samples and gently mixed several times. The plate was then 
incubated for 30 seconds (in the dark) and measured directly using GloMax®-
Multi
+
 Microplate Multimode Reader. The luminometer was set to 1 second 
integration. All experiments were done in duplicate. 
 
2.17 Electrophoretic mobility shift assay (EMSA) 
The electrophoretic mobility shift assay (supplied by Thermo™ Scientific) was 
used to study DNA-protein interactions. The principle is based on the fact that 
protein-nucleic acid complexes migrate more slowly than the corresponding free 
nucleic acid, in a polyacrylamide or agarose gel. This in turn results in a “shift” in 
the migration of labelled DNA. The Thermo Scientific Light Shift® 
Chemiluminescent EMSA kit was used, as it uses a non-isotopic approach to 
detect DNA-protein interactions. For the detection of biotinylated labelled DNA, 
the Streptavidin-Horseradish Peroxidase conjugate as well as the 
Chemiluminescent substrates was used.  
 
2.17.1 Annealing of complementary pairs of oligonucleotides 
A Rattus norvegicus Hsp70 sequence (Gene accession: NM_031971) was used for 
the design of the oligonucleotides. Promoter sequences were extracted as 
described in section 2.5.1, followed by the identification of conserved sequences 
(promoter modules) in the promoter region of Hsp70. CLUSTALW was used to 
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identify highly conserved nucleotide sites in the promoter modules, and these 
highly conserved nucleotide sites were used for the creation of mutant 
oligonucleotides. Biotinylated labelled oligonucleotides (mutant) were generated 
by Inqaba Biotec™.  
 
A concentration of 60 fmol of consensus oligonucleotides (labelled and unlabelled 
as shown in table 2.3) were incubated in a sterile thin walled PCR tube. The same 
was done for the mutant oligonucleotides (labelled and unlabelled). The annealing 
reaction was performed in a PCR machine by incubating the tube at 80°C for 10 
minutes and then dropping the temperature every 10 minutes until it reached room 
temperature. 
 
Table 2.3 Mutant DNA sequences for SP1F_KLFS_01  
 Forward Primer Reverse Primer 
Labelled Mutant oligonucleotide 5’-Biotin- GAGGGTATACTGGGCCGG- 3’ 5’-Biotin- CCGGCCCAGTATACCCTC- 3’ 
 
 2.17.2 Control and experimental binding reactions with annealed 
oligonucleotides 
Electrophoretic mobility gel shift experiments were carried out according to the 
protocol supplied by the ThermoScientific LightShift® Chemiluminescent EMSA 
kit.  
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Total cellular protein extracts were prepared (section 2.13) from p11 H9c2 
cardiomyocytes (1 hour heat shock at 42 °C, and 24 hour recovery at 37 °C) and 
used for all gel shift experiments. Polyacrylamide gels (4%) were prepared 
according to table 2.2. The assembly of the PAGE was similarly prepared as 
described in section 2.15.1 
Table 2.4 Materials used for the preparation of two 4% SDS- polyacrylamide gel  
              Solutions                               5% Resolving gel 
Distilled water 
40% Acrylamide (37:5:1) 
1.5 M Tris pH8.8 
10 % sodium dodecyl 
sulphate (SDS) 
10 % Ammonium persulphate 
(APS) 
10.1 ml 
1.6 ml 
                    4 ml 
 0.160 ml  
 
0.160 ml 
 
TEMED                                   0.016 ml 
 
Once gels were poured it was pre-electrophoresed at 120V for 30 minutes in a 
Mini-Protean tetra cell chamber (BIO-RAD).   
Control (C1, C2 and C3) and experimental (E1, E2 and E3) binding reactions 
were prepared in 1.5 ml sterile Eppendorf tubes according to tables 2.5 and 2.6, 
respectively.  The binding reactions were then incubated for 20 minutes at room 
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temperature, followed by the addition of 5 μl of 5X loading buffer to each binding 
reaction. Gels were electrophoresed for approximately 40 minutes at 100V until 
the bromophenol blue dye has migrated half way down the gel. Once the gel was 
completed, proteins and DNA were transferred to a positively charged nylon 
transfer membrane (Hybond- N+) in a clean electrophoresis unit. Proteins were 
transferred in a Mini-Protean tetra cell chamber (BIO-RAD) for 30 minutes at a 
voltage of 100 V in cooled 0.5X TBE. The transferred DNA was crosslinked to 
the membrane with the use of a UV Stratalinker 2400 (Stratagene) crosslinking 
machine, equipped with 254nm bulbs. Crosslinking was done by using the auto-
crosslinking function for 1 minute.  
The detection of biotin-labeled DNA, on the nylon membrane, was done with the 
aid of the Supersignal® West Pico Chemiluminescent Subtrate (Thermo 
Scientific), as well as a ChemiDoc UVP system (membrane exposure of 10 
seconds – 4 minutes).  
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Table 2.5 The Control binding reactions for the EMSA system. 
Reagents Final 
concentration 
           C1                    C2                   C3 
Ultrapure water - 12 μl 11 μl 9 μl 
10X binding buffer 1X 2 μl 2 μl 2 μl 
50% Glycerol 2.5% 1 μl 1 μl 1 μl 
100mM MgCl2 5mM 1 μl 1 μl 1 μl 
1 μg/μl Poly (dI•dC) 50 ng/μl 1 μl 1 μl 1 μl 
1% NP-40 0.05% 1 μl 1 μl 1 μl 
Unlabeled EBNA 
DNA (from 
Genecopeia™ kit) 
4 pmol - - 2 μl 
EBNA Extract (from 
Genecopeia™ kit) 
1 Unit - 1 μl 1 μl 
Biotin-EBNA Control 
(from Genecopeia™ 
kit) DNA 
          20 fmol 2 μl 2 μl 2 μl 
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Table 2.6 The Experimental binding reactions for the heat shocked test system 
Reagents Final 
concentration 
           E1                   E2                   E3 
Ultrapure water - 5 μl 4 μl - 
10X binding buffer 1X 2 μl 2 μl  2 μl 
1 μg/μl Poly (dI•dC) 50 ng/μl 1 μl 1 μl 1 μl 
50% Glycerol 2.5% - - - 
100mM MgCl2 5mM - - - 
1% NP-40 0.05% - - - 
Protein Extract  (heat 
shocked and non-heat 
shocked lysates) 
1 Unit - 1 μl 1 μl 
Biotin-labeled 
SP1F_KLFS_01 
oligonucleotides 
(consensus) 
60 fmol 12 μl 12 μl 12 μl 
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CHAPTER 3: RESULTS AND DISCUSSION 
The aim of this study was to identify novel CAREs that are involved in the 
regulation of the expression of heat shock response genes. Genes that are 
functionally related (e.g. heat shock responsiveness) will be regulated in the same 
way (Werner, 2001). These genes may therefore also be regulated by the same 
TFs and consequently these genes may have the similar CAREs in their promoter 
regions. It is thus possible that genes encoding heat shock response proteins share 
a sequence signature in their promoter region, which regulates the expression of 
these genes in response to heat stress. Identifying these CAREs will give us 
insights on gene expression of heat shock responsive genes and their functional 
characteristics. These novel CAREs can also be beneficial in therapeutic 
advances, by turning gene expression “on” where it was previously turned “off” 
(Garrett and Grisham, 2005). TFs will recognize specific nucleotide sequences 
(motifs/CAREs), which are located before or after the gene and turn “on” gene 
expression (Phillips, 2008). 
An in silico approach was used to identify CAREs that are shared by known heat 
shock response genes. This was followed by an in vitro approach to evaluate the 
involvement of these CAREs in the regulation of gene expression in response to 
heat stress.  
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3.1 The identification of promoter sequences of known heat shock responsive 
genes. 
 The promoter sequences for well-known heat shock responsive genes were 
identified with the use of the Gene2Promoter tool in the Genomatix software 
(http://www.genomatix.de). Gene2Promoter is an online software tool used to 
identify promoter sequences in all query gene sequences. This is done by 
identifying the locus in a query gene sequence and alternatively listing all 
transcripts and promoters specific for that locus (http://www.genomatix.de). 
Using the search term “heat shock”, 50 genes (from Rattus norvegicus species) 
were identified (Table 3.1). These genes included the well-known heat shock 
proteins Hsp70, Hsp90 and αβ-crystalline (Wyttenbach and Arrigo, 2000). The 
Gene2Promoter tool identifies three categories of promoter sequences, namely (1) 
experimentally verified promoter sequences, (2) in silico predicted promoter 
sequences that were verified using the PromoterInspector tool 
(http://www.genomatix.de), and (3) in silico predicted promoter sequences that 
were not verified in any way. Experimentally verified promoter sequences are 
promoters that were confirmed using in vitro assays such as promoter mapping as 
the functional promoter for a particular gene (http://www.genomatix.de). 
PromoterInspector is an online software tool which predicts promoter regions with 
high specificity in mammalian genomic sequences (http://www.genomatix.de). In 
this study, only promoter sequences from categories (1) and (2) were considered.  
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The promoter sequences for only 19 (Table 3.2) out of the 50 heat shock 
responsive genes (38 %) were either previously experimentally verified or verified 
using the PromoterInspector tool. The table in Appendix 1 shows the promoter 
sequences for these genes. The promoter sequences for genes that were in silico 
predictions, and not verified, were not considered in this study. 
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3.2 The identification of common promoter modules in the promoter 
sequences of known heat shock genes. 
The promoter sequences for the 19 known heat shock responsive genes were 
analysed using the ModelInspector tool (www.genomatix.de) to identify all the 
promoter modules (i.e. potential TF binding sites) the promoter regions of these 
genes. ModelInspector is an online software tool which uses a library of 
predefined models to search DNA sequences for matches to these models. A 
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model would consist of various individual sequence elements (e.g. TF binding 
sites, hairpins, repeats etc.). (http://www.genomatix.de). Table 3.2 shows a 
summary of the results. 
CAREs that are statistically over represented in the promoter sequences of genes 
that share a common function may also regulate the expression of these genes. 
The most common promoter module in the promoter regions of the19 heat shock 
responsive genes was SP1F_KLFS_01 (a total of 15 promoters contained 
SP1F_KLFS_01 sequence). SP1F_KLFS_01 is a promoter module that consists of 
two overlapping TF binding sites, which are SP1F (Specificity protein 1 or GC 
box factor) and KLF (Kruppel-like factor), these binding sites enable the binding 
of SP1F and KLFs TFs (McConnell and Yang, 2010). According to Augustin et 
al, GC box factor, plays a vital role in chromatin silencing and embryonic 
development, whereas KLF assists in the development and stress response 
mechanism to external stress (Augustin et al., 2011). KLFs have been studied 
extensively for their role in cell proliferation, differentiation and cell survival in 
the context of cancer (McConnell and Yang, 2010). KLFs also share a high degree 
of homology with the SP1 family of zinc-finger TFs. It has been shown that the 
multiple SP1 TFs are highly responsive to the stressful stimuli such as ethanol 
exposure (Wilke et al., 2000). KLF4 and KLF5 (two closely related members of 
the KLFs family) respond to numerous external stressful stimuli and are involved 
in restoring cellular homeostasis following exposure to stressors (McConnell et 
al., 2007).  It is therefore possible that SP1F and KLF work together to regulate 
the expression of heat shock responsive genes following heat stress. 
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3.3 Sequence analysis of the SP1F_KLFS_01 modules in the promoter 
sequences of heat shock responsive genes.  
A sequence alignment (Table 3.4) of the SP1F_KLFS_01 modules identified in 
the promoter sequences of the 15 heat shock response genes shows a high degree 
of conservation of 5 nucleotides (5-CGCCC-3) in the SP1F_KLFS_01 modules. 
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Table 3.4 Sequence alignment of SP1F_KLFS_01 sequences of genes 
encoding heat shock responsive proteins. The sequence alignment was 
performed using CLUSTALW2.1 (Chenna et al., 2003). A total of 24 
SP1F_KLFS_01 sequences from the 15 genes were aligned. The asterisk 
under the sequence alignment indicate the conserved nucleotides (5-
CGCCC-3). 
Promoter Name Sequence Alignment 
Heat shock protein 4-like_2 -----CCCCCCCCGCCCGT---GACA- 18 
Heat shock protein 90, beta, member 1_1 -----CGTCCCCCGCCCGC---AAGC- 18 
Heat repeat containing  2_1 -----CACGCCCCGCCCAT---TTGG- 18 
Heat shock protein 4-like_1 -----GCCGCCCCGCCCTG---CCCT- 18 
Heat shock protein 90, beta, member 1_2 -----TCCACCCCGCCCAA---CCCG- 18 
Heat shock transcription factor 4_1 TGCCGCCCGCCCCGCCCTA---CTCC- 23 
Heat shock transcription factor 4_1a   TGCCGCCCGCCCCGCCCTA---CTCC- 23 
Heat shock 70kD protein 1B (mapped) (Hspa1b) -----CCGGCCCCGCCCAC---CCTC- 18 
Heat shock protein 4-like_1 -----TCCGGGACGCCCCC---CCCC- 18 
Heat shock protein 90, alpha (cytosolic),  class B member 1 -----TCTTCCCCGCCCCC---TCCC- 18 
Heat repeat containing  2_2 -----CTGGTCCCGCCCTTTACCCCTT 22 
Heat shock protein 1 (chaperonin 10)_2 -----GCGGCCCCGCCCT----CCTTA 18 
PDGFA associated protein 1 -----GGGGCCCCGCCCA----CCTCG 18 
Heat shock protein 90, alpha (cytosolic),  class A member 1 -----CGGGCCCCGCCCCT---CCAC- 18 
Heat repeat containing  1_1 -----GGAGCCCCGCCCCC---T-CCA 18 
Heat shock protein 2_2 -----TGAGCCCCGCCCAG---TGCC- 18 
Heat shock protein 2_1 -----CGCGCCCCGCCCCG---CGCC- 18 
Heat shock protein 1 (chaperonin 10)_1 -----CCGGCCCCGCCCCG---CGGC- 18 
AHA1,  activator of heat shock protein ATPase homolog 2 
(yeast)_2 
-----CCTGCCCCGCCCCG---CTGC- 18 
Heat repeat containing  1_2 -----AAAGCCCCGCCCTC---CGCT- 18 
DnaJ (Hsp40) homolog, subfamily A, member 1_1 -----GAAGTCCCGCCCCT---CGCTT 19 
Heat shock protein 90 alpha (cytosolic),  class B member 1_2 -----CTAGCCCCGCCCTT---GGAT- 18 
AHA1,  activator of heat shock protein ATPase homolog 2 
(yeast)_1 
-----AAGACCCCGCCCTA---TGCG- 18 
AHA1,  activator of heat shock protein ATPase homolog 2 
(yeast)_3 
-----AAGTCCCCGCCCCG---GGCC- 18 
           .*****           
 
Table 3.3 ModelInspector output data representing SP1F_KLFS_01 modules identified in heat shock responsive promoters.   
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3.4 The generation of promoter reporter constructs for Hsp70 
To investigate whether the SP1F_KLFS_01 module is involved in the regulation 
of the expression of heat shock responsive genes, the GLuc-ON™ promoter 
constructs from GeneCopoeia Inc. was used. The GLuc-ON™ promoter 
constructs from GeneCopoeia Inc. are designed to perform promoter analysis in 
real-time (http://www.genecopoeia.com). The dual-reporter system uses Gaussia 
luciferase (GLuc) as the promoter reporter and Secrete Alkaline Phosphatase 
(SEAP) as the internal control for signal normalization. The promoter sequence 
(in this case the rat Hsp70 promoter) was cloned upstream (on the 5´ end) of the 
GLuc gene. Hsp70 was used since it is a well-known heat shock responsive gene 
and since it was shown in this study to contain one SP1F_KLFS_01 module 
(Figure 3.1) in its promoter sequence.  
Two constructs were generated: the one construct (pEZX-pG04) contained the 
wild type rat Hsp70 promoter, while the second construct (pEZX-pG04-Mut) 
contained a mutated version of the rat Hsp70 promoter. Both constructs were 
purchased from GeneCopoeia Inc. In the mutated Hsp70 promoter (pEZX-pG04-
Mut) the conserved nucleotides (5-CGCCC-3) in the SP1F_KLFS_01 module 
was replaced with a mutated (5-ATACT-3) sequence. DNA sequence data for 
pEZX-pG04 and pEZX-pG04-Mut was supplied by GeneCopoeia Inc. Figure 3.2 
shows a sequence alignment between the Hsp70 promoter sequence 
(>GXP_2964156) and the promoter region of pEZX-pG04, while Figure 3.3 
shows an alignment between the Hsp70 promoter sequence (>GXP_2964156) and 
the promoter region of pEZX-pG04-Mut. A 100% match between Hsp70 
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promoter and the promoter region of pEZX-pG04 was obtained, while a 99 % 
match was obtained for the Hsp70 promoter and the promoter region of pEZX-
pG04-Mut. Four mismatches were observed between the Hsp70 promoter and the 
promoter region of pEZX-pG04-Mut. These mismatches correspond to the four-
nucleotide replacements (5-ATACT-3) in the SP1F_KLFS_01 module of the 
promoter region of pEZX-pG04-Mut. 
 
>GXP_2963156(Hspa1b/rat) loc=GXL_187112|sym=Hspa1b|geneid=294254| acc 
=GXP_2963156| taxid=10116|spec=Rattusnorvegicus|chr=20 |ctg=NC_005 11 9| 
str=(+)|start=3955107|end=3955707|len=601|tss=501|descr=heat shock 70kD 
protein 1B (mapped)| comm=GXT_23117308/ ENSRNOT0000004966 7/501 
/bronze 
5´- GCCAAGCGTTATCCCTCCCGTTTTGAGAAACTTTCTGCGTCCGCCATCCTGTAGGA 
AGAATTTGTACACCTTAAACTCCCTCCCTGGTCTGATTCCCAAATGTCTCTCACCGCCC
AGCACTTTCAGGAGCTGACCCTTCTCAGCTTCACATACAGAGACCGCTACCTTGCGTC
GCCATGGCAACACTGTCACAACCGGAACAAGCACTTCCTACCACCCCCCGCCTCAGG
AATCCAATCTGTCCAGCGAAGCCCAGATCCGTCTGGAGAGTTCTGGACAAGGGCGGT
ACCCTCAACATGGATTACTCATGGGAGGCGGAGAAGCTCTAACAGACCCGAAACTGC
TGGAAGATTCCTGGCCCCAAGGCCTCCTCCCGCTCGCTGATTGGCCCATGGGAGGGTG
GGCGGGGCCGGAGGAGGCTCCTTAAAGGCGCAGGGCGGCGCGCAGGACACCAGATT
CCTCCTCCTAATCTGACAGAACCAGTTTCTGGTTCCACTCGCAGAGAAGCAGAGAAGC
GGAGCAAGCGGCGCGTTCCAGAACCTCGGGCAAGACCAGCCTCTCCCAGAGCATCCC
CACCGCGAAGCGCAACCTTCTCCAGAGC- 3´ 
Figure 3.1 The promoter sequence of Hsp70. The promoter sequence of the 
rat Hsp70 gene as identified by Gene2Promoter is shown. The 
SP1F_KLFS_01 sequence is highlighted in yellow. 
 
 
 
 
 
 
 
72 
 
Query  1     GCCAAGCGTTATCCCTCCCGTTTTGAGAAACTTTCTGCGTCCGCCATCCTGTAGGAAGAA  60 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1015  GCCAAGCGTTATCCCTCCCGTTTTGAGAAACTTTCTGCGTCCGCCATCCTGTAGGAAGAA  1074 
 
Query  61    TTTGTACACCTTAAACTCCCTCCCTGGTCTGATTCCCAAATGTCTCTCACCGCCCAGCAC  120 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1075  TTTGTACACCTTAAACTCCCTCCCTGGTCTGATTCCCAAATGTCTCTCACCGCCCAGCAC  1134 
 
Query  121   TTTCAGGAGCTGACCCTTCTCAGCTTCACATACAGAGACCGCTACCTTGCGTCGCCATGG  180 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1135  TTTCAGGAGCTGACCCTTCTCAGCTTCACATACAGAGACCGCTACCTTGCGTCGCCATGG  1194 
 
Query  181   CAACACTGTCACAACCGGAACAAGCACTTCCTACCACCCCCCGCCTCAGGAATCCAATCT  240 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1195  CAACACTGTCACAACCGGAACAAGCACTTCCTACCACCCCCCGCCTCAGGAATCCAATCT  1254 
 
Query  241   GTCCAGCGAAGCCCAGATCCGTCTGGAGAGTTCTGGACAAGGGCGGTACCCTCAACATGG  300 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1255  GTCCAGCGAAGCCCAGATCCGTCTGGAGAGTTCTGGACAAGGGCGGTACCCTCAACATGG  1314 
 
Query  301   ATTACTCATGGGAGGCGGAGAAGCTCTAACAGACCCGAAACTGCTGGAAGATTCCTGGCC  360 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1315  ATTACTCATGGGAGGCGGAGAAGCTCTAACAGACCCGAAACTGCTGGAAGATTCCTGGCC  1374 
 
Query  361   CCAAGGCCTCCTCCCGCTCGCTGATTGGCCCATGGGAGGGTGGGCGGGGCCGGAGGAGGC  420 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1375  CCAAGGCCTCCTCCCGCTCGCTGATTGGCCCATGGGAGGGTGGGCGGGGCCGGAGGAGGC  1434 
 
Query  421   TCCTTAAAGGCGCAGGGCGGCGCGCAGGACACCAGATTCCTCCTCCTAATCTGACAGAAC  480 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1435  TCCTTAAAGGCGCAGGGCGGCGCGCAGGACACCAGATTCCTCCTCCTAATCTGACAGAAC  1494 
 
Query  481   CAGTTTCTGGTTCCACTCGCAGAGAAGCAGAGAAGCGGAGCAAGCGGCGCGTTCCAGAAC  540 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1495  CAGTTTCTGGTTCCACTCGCAGAGAAGCAGAGAAGCGGAGCAAGCGGCGCGTTCCAGAAC  1554 
 
Query  541   CTCGGGCAAGACCAGCCTCTCCCAGAGCATCCCCACCGCGAAGCGCAACCTTCTCCAGAG  600 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1555  CTCGGGCAAGACCAGCCTCTCCCAGAGCATCCCCACCGCGAAGCGCAACCTTCTCCAGAG  1614 
 
Query  601   C  601 
             | 
Sbjct  1615  C  1615  
Figure 3.2 Sequence alignment between the Hsp70 promoter and the promoter 
region of pEZX-pG04. BLAST (Altschul et al., 1990) was used to align the 
Hsp70 promoter sequence (Query sequence) and the pEZX-pG04 (Sbjct 
sequence). The position of the SP1F_KLFS_01 sequence in both the Hsp70 
promoter sequence and the promoter region of pEZX-pG04 are highlighted in 
yellow.  
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Query  1     GCCAAGCGTTATCCCTCCCGTTTTGAGAAACTTTCTGCGTCCGCCATCCTGTAGGAAGAA  60 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  7707  GCCAAGCGTTATCCCTCCCGTTTTGAGAAACTTTCTGCGTCCGCCATCCTGTAGGAAGAA  7766 
 
Query  61    TTTGTACACCTTAAACTCCCTCCCTGGTCTGATTCCCAAATGTCTCTCACCGCCCAGCAC  120 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  7767  TTTGTACACCTTAAACTCCCTCCCTGGTCTGATTCCCAAATGTCTCTCACCGCCCAGCAC  7826 
 
Query  121   TTTCAGGAGCTGACCCTTCTCAGCTTCACATACAGAGACCGCTACCTTGCGTCGCCATGG  180 
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  7827  CTTCAGGAGCTGACCCTTCTCAGCTTCACATACAGAGACCGCTACCTTGCGTCGCCATGG  7886 
 
Query  181   CAACACTGTCACAACCGGAACAAGCACTTCCTACCACCCCCCGCCTCAGGAATCCAATCT  240 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  7887  CAACACTGTCACAACCGGAACAAGCACTTCCTACCACCCCCCGCCTCAGGAATCCAATCT  7946 
 
Query  241   GTCCAGCGAAGCCCAGATCCGTCTGGAGAGTTCTGGACAAGGGCGGTACCCTCAACATGG  300 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  7947  GTCCAGCGAAGCCCAGATCCGTCTGGAGAGTTCTGGACAAGGGCGGTACCCTCAACATGG  8006 
 
Query  301   ATTACTCATGGGAGGCGGAGAAGCTCTAACAGACCCGAAACTGCTGGAAGATTCCTGGCC  360 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  8007  ATTACTCATGGGAGGCGGAGAAGCTCTAACAGACCCGAAACTGCTGGAAGATTCCTGGCC  8066 
 
Query  361   CCAAGGCCTCCTCCCGCTCGCTGATTGGCCCATGGGAGGGTGGGCGGGGCCGGAGGAGGC  420 
             |||||||||||||||||||||||||||||||||||||||||   | |||||||||||||| 
Sbjct  8067  CCAAGGCCTCCTCCCGCTCGCTGATTGGCCCATGGGAGGGTATACTGGGCCGGAGGAGGC  8126 
 
Query  421   TCCTTAAAGGCGCAGGGCGGCGCGCAGGACACCAGATTCCTCCTCCTAATCTGACAGAAC  480 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  8127  TCCTTAAAGGCGCAGGGCGGCGCGCAGGACACCAGATTCCTCCTCCTAATCTGACAGAAC  8186 
 
Query  481   CAGTTTCTGGTTCCACTCGCAGAGAAGCAGAGAAGCGGAGCAAGCGGCGCGTTCCAGAAC  540 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  8187  CAGTTTCTGGTTCCACTCGCAGAGAAGCAGAGAAGCGGAGCAAGCGGCGCGTTCCAGAAC  8246 
 
Query  541   CTCGGGCAAGACCAGCCTCTCCCAGAGCATCCCCACCGCGAAGCGCAACCTTCTCCAGAG  600 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  8247  CTCGGGCAAGACCAGCCTCTCCCAGAGCATCCCCACCGCGAAGCGCAACCTTCTCCAGAG  8306 
 
Query  601   C  601 
             | 
Sbjct  8307  C  8307  
Figure 3.3 Sequence alignment between the Hsp70 promoter and the promoter 
region of pEZX-pG04-Mut. BLAST (Altschul et al., 1990) was used to align the 
Hsp70 promoter sequence (Query sequence) and the pEZX-pG04-Mut (Sbjct 
sequence). The position of the SP1F_KLFS_01 sequence in both the Hsp70 
promoter sequence and the promoter region of pEZX-pG04-Mut are highlighted 
in yellow. 
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3.5 The transfection of H9c2 cells with pEZX-pG04 and pEZX-pG04-Mut. 
Large-scale plasmid DNA preparations of pEZX-pG04 and pEZX-pG04-Mut 
were generated as described in Section 2.9.1 (Figure 3.4) Lane 2 and 3 shows the 
3 forms of plasmid DNA (supercoiled, nicked and linear). 
H9c2 cells were transfected with 2 μg of the two plasmids as described in Section 
2.11.5 using MetafectenePro™. Figure 3.5 shows the results of the transfection 
after 12 days of selection in 0.5 μg/ml puromycin. Cells that are successfully 
transfected with either pEZX-pG04 or pEZX-pG04-Mut should be resistant to 
puromycin treatment since the plasmid carries the puromycin resistance gene. 
Treatment with 0.5 μg/ml puromycin will kill all the cells that are not transfected 
with the plasmid. Figure 3.5 (B) shows that untransfected cells that were treated 
with 0.5 μg/ml puromycin did not survive the selection process. No viable cells 
were present in the well. Cells that were stably transfected with pEZX-pG04 (C) 
and pEZX-pG04-Mut (D) survived the selection process, suggesting that the cells 
were successfully transfected with the plasmid DNA. H9c2 cells successfully 
transfected with pEZX-pG04 and pEZX-pG04-Mut were renamed H9c2-Hsp70 
and H9c2-Hsp70-Mut, respectively. H9c2-Hsp70 cells can therefore be used as a 
reporter for wild type Hsp70 promoter, while H9c2-Hsp70-Mut cells can be used 
as a reporter for the mutant Hsp70 promoter.  
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Figure 3.4 Large-scale plasmid DNA preparation of pEZX-pG04 and pEZX-
pG04-Mut. Lane M is the GeneRuler 1kb DNA ladder, Lane 1 is the plasmid 
preparation of pEZX-pG04 and Lane 2 is the plasmid preparation of pEZX-pG04-
Mut. 
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Figure 3.5 H9c2 cells transfected with pEZX-pG04 and pEZX-pG04-Mut. A 
shows the untransfected cells, B shows cells untransfected treated for 12 days 
with 0.5 μg/ml puromycin, C shows cells that were transfected with 2 μg pEZX-
pG04 and treated with 0.5 μg/ml puromycin (generating H9c2-Hsp70 cells) and D 
shows cells that were transfected with 2 μg pEZX-pG04-Mut and treated with 0.5 
μg/ml puromycin (generating H9c2-Hsp70-Mut cells). The images were taken at 
20 times magnification using the Nikon microscope fitted with a Leica camera. 
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3.6 The expression of Hsp70 in response to heat stress. 
It is known that heat stress induces the expression of Hsp70 (Mosser et al., 1997). 
Heat stress can therefore be used as a stimulus to evaluate Hsp70 promoter 
activity. To confirm that Hsp70 is induced by heat stress, H9c2 cells were 
exposed to 42 °C for 1 hour and the expression of Hsp70 was evaluated by 
Western blot analysis 1, 4, 6 and 24 hours after exposure to heat stress. Total 
protein lysates were prepared using the Cytobuster™ Protein Extraction Reagent 
(as described in Section 2.13). Figure 3.6 A shows the total protein lysates 
isolated from the cells and Figure 3.6 B shows the Western blot analysis. Figure 
3.6 A demonstrates that equal quantities of the protein samples were loaded on the 
gel. The Western blot (Figure 3.6 B) shows that the expression levels of Hsp70 
increase significantly 6 hours after exposure to heat stress and remains elevated at 
24 hours.  
 
This suggests that the activity of the Hsp70 promoter will also increase 6 hours 
after exposure to heat stress and that this would be the appropriate time point to 
assess Hsp70 promoter activity.  
 
 
 
 
78 
 
 
Figure 3.6 Analysis of Hsp70 expression in response to heat stress. H9c2 cells 
were exposed 42 °C for 1 hour and allowed to recover for 1, 4, 6, 24 hours. Total 
protein lysates were prepared and analysed by SDS-PAGE (A).  Lane 1 is the 
Spectra Multi-colour Broad Range Protein Ladder (Fermentas) and Lane 2 (Non-
heat shocked or NHS) is a lysate prepared from H9c2 cells that were not subjected 
to heat stress. Lanes 3, 4, 5 and 6 are lysates prepared from H9c2 cells that were 
subjected to heat stress and allowed to recover for 1, 4, 6 and 24 hours, 
respectively. A Western blot analysis was performed on the same samples using 
an anti-Hsp70 antibody (B). 
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3.7 The Hsp70 promoter reporter assay 
Based on the in silico analysis of the promoter sequences of heat shock response 
genes, it was suspected that the SP1F_KLFS_01 promoter module is involved in 
the regulation of the gene expression of heat shock responsive genes such as 
Hsp70. To evaluate the involvement of the SP1F_KLFS_01 promoter module in 
regulating the expression of heat shock responsive genes, two cells lines H9c2-
Hsp70 and H9c2-Hsp70-Mut were generated. H9c2-Hsp70 can be used in reporter 
assays for the Hsp70 promoter, while the H9c2-Hsp70-Mut can be used in the 
reporter assays for the mutant Hsp70 promoter. Hsp70 promoter activity was 
evaluated in H9c2, H9c2-Hsp70 and H9c2-Hsp70-Mut cells following exposure to 
heat stress. The cells were cultured in 6 well plates and exposed to 42 °C for 1 
hour as described in Section 2.12. Hsp70 promoter activity was assessed in these 
cells by measuring the luciferase activity 1, 4, 6, and 24 hours after heat stress as 
described in Section 2.16 (Figure 3.7). Since H9c2 cells were not transfected 
(Figure 3.5), no luciferase activity was observed in these cells. Both H9c2-Hsp70 
and H9c2-Hsp70-Mut cells demonstrated a time dependent increase in luciferase 
activity between 4 and 24 hours after exposure to heat stress. This is in line with 
the Western blot result, which showed that the expression levels of Hsp70 
increase 6 hours after exposure to heat stress. However, Figure 3.7 also shows that 
there is no significant difference in the Hsp70 promoter activity in H9c2-Hsp70 
and H9c2-Hsp70-Mut cells. This suggests that the mutation that was introduced 
into the Hsp70 promoter in H9c2-Hsp70-Mut cells did not affect the activity of 
the promoter. Furthermore, it also suggests that the SP1F_KLFS_01 promoter 
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module may not be involved in the regulation of the expression of heat shock 
response genes. 
 
 
Figure 3.7 Hsp70 promoter activity in H9c2-Hsp70 and H9c2-Hsp70-Mut cells.  
A) Gaussia Luciferase (GLuc) assay for high sensitivity, using GL-H buffer. 
Indicating increased luciferase promoter expression after 1, 4, 6 and 24 hour 
recovery in both the H9c2-Hsp70 and H9c2-Hsp70-Mut cells.  
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3.8 Evaluating protein binding to SP1F_KLFS_01 sequence following heat 
shock 
The promoter reporter assay could not confirm the involvement of 
SP1F_KLFS_01 promoter module in the control of Hsp70 expression.  Therefore, 
a second experimental approach was used to evaluate the involvement of 
SP1F_KLFS_01. The Electrophoretic mobility shift assay (EMSA) can be used to 
study the possible interaction between DNA-binding proteins and DNA. The 
principle of the assay is based on the fact that DNA-protein complexes migrates 
slower on a gel compared to unbound DNA (Holden  and Tacon, 2011). EMSA 
analysis is often used to show the binding of the TFs to their respective sites in the 
cis-regulatory elements (Werner, 2001). As shown in Figure 3.7, Hsp70 promoter 
activity incresed after a recovery period of 4 hours, and continues until 24 hours. 
It is therefore expected that TFs that regulate the expression of Hsp70 and other 
heat shock responsive proteins, will be present in the proteome of the cells at this 
time point. If SP1F_KLFS_01 is involved in the regulation of Hsp70 expression 
then proteins present in a cell lysate, prepared at this time point, should bind to a 
synthetic copy of the SP1F_KLFS_01 sequence. H9c2 cells were therefore 
subjected to heat shock, allowed to recover for 1, 4, 6 and 24 hours and total 
cellular proteins were extracted using Cytobuster ™ Extraction Reagent (Section 
2.13). For this experiment the 24 hour recovery sample was used as it showed the 
highest expression in the Western blot analysis. The EMSA was performed as 
described in Section 2.17. A biotin-labelled probe representing the 
SP1F_KLFS_01 sequence was used as the target. Figure 3.8 shows a pronounced 
shift for the Biotin-EBNA control DNA binding to the proteins present in the 
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EBNA protein extract (Lane 2). However, no shift was observed when the Biotin-
SP1F_KLFS_01 probe was incubated with the protein lysate prepared from heat 
shocked cells (Lane 5).  
                               
Non- HS lysate         -        -       -        -        +       -         
HS lysate                            -         -        -        -        -       +        
Biotin-SP1F_KLFS 
 probe                                 -         -         -        +       +      +         
Unlabelled EBNA DNA    -         -        +        -        -       -             
EBNA Extract                   -         +        +        -        -       -         
Biotin-EBNA Control       +        +        +        -        -       -         
DNA   
 
Figure 3.8 Electrophoretic Mobility Shift Assay (EMSA) investigating the 
binding of SP1F_KLFS_01 to protein lysate and showing no binding of protein 
(heat shocked and non-heat shocked lysates) to DNA. 
 
The EMSA results clearly validated the promoter reporter assay data by showing 
that SP1F_KLFS_01 is not a target for TFs expressed in H9c2 cells after heat 
shock, and that this promoter module is probably not involved in the regulation of 
heat shock response in these cells. However, it is possible that binding of the 
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proteins to SP1F_KLFS_01 was affected by the fact that total cellular protein 
lysate as opposed to nuclear lysates was used.  
 
Future directions  
Seeing that in vitro experiments of this study did not support the findings of the in 
silico experiments, there are various steps which could be taken to further 
investigate the involvement of cis-acting regulatory elements in the regulation of 
heat shock.  
Other promoter modules could be investigated, such as SMAD_E2FF_01 and 
E2FF_SP1F_01 to verify the regulation of the heat shock response in 
cardiomyocytes.  
Nuclear extracts should be extracted from protein lysates opposed to total cellular 
extract to ensure that the correct experimental procedure for the EMSA 
experiment in followed.  
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APPENDIX 1 
Promoter sequences for heat shock responsive genes  
  
 
 
>GXP_3419496(Hspa5/rat) loc=GXL_246319 |sym=Hspa5|geneid=25617 |acc=GXP_3419496| 
taxid=10116|spec=Rattus norvegicus| chr=3|ctg=NC_005102|str=(+)| start=13783636| 
end=13784237|len=602|tss=501|descr=heat shock protein 5|comm=GXT_24675410/ 
trans_ENSMUST00000145466/501/silver 
GCGCGCTCGATACTGGCTGTGACTACACTGACTTGGACACTTGGCCTTTTGCGGGTTTGAGAGGTAAGCGTCG
CGGCCTGCTTCCAGGCCTACCCTGATTTTGGTTCGTGGCTCCTCCTGACCCTGAGACCTCTGTCGCCCTCAGAT
CAGAACCGTCGTCGCGTTTCGGGGCTACAGCCTGTTGCTGGACTCTGTGAGACACCTGACCGACCGCTGAGCG
ACTGACTGGTCCACAGCGCCGGCAAGATGAAGTTCACTGTGGTGGCGGCGGCGCTGCTGCTGCTGTGTGCGG
TGCGGGCGGAGGAGGAGGACAAGAAGGAGGATGTAGGCACGGTGGTTGGCATCGACTTGGGGACCACCTA
TTCCTGGTAAGTGGCAATCGTCGGAGGAGGTTGGGGGGGGGGAGTGGGGCGTGGCCTCCGGGGCTACCGT
GAGAAAGTGCGGTGCTGATTCCTTTTCTGTGGGGTTTTCCCATCAGCGTCGGTGTATTCAAGAACGGCCGCGT
GGAGATCATAGCCAACGATCAGGGCAACCGCATCACACCGTCGTATGTGGCCTTCACTCCTGAAGGGGAGCG
TCTGATTGGCGATGCGGCCAAGAAC 
>GXP_1149850(Heatr2/rat) loc=GXL_622470|sym=Heatr2|geneid=304332| acc=GXP_1149850| 
taxid=10116|spec=Rattus norvegicus|chr=12|ctg=NC_005111|str=(-)|start=15994871| 
end=15995471|len=601|tss=501|descr=HEAT repeat containing 2|comm=GXT_23485096/ 
NM_001134857/501/silver;GXT_24168388/ENSRNOT00000035545/501/silver 
TCGCCCTGCCTACAAAAGACAACGCTCCGCCTGCCACCTCCTGCAACGCTCCCAAAGTCCACGCCCCGCCCATT
TGGTTCTTTTCCCTCCCATTACACGTTATTCCCCACTCTTCACACTAAGCCTCTACCCAAGAGGCCTGTGTCCCG
CCTACCACCCCCTCGTACCGCCCACTACCCAAGGCCCTTGAGGAGCTTGCTGCCTCCTGCCTCGCCCTCGAGGT
TCTCGCCCCACCCTCGACTCCTAGACTCAGCCAATAACACTTTCTCTTCGCCCCCTCTCTCGTCCCCCTGCCCGCT
ACTCCGCCCTCTAAGCCCTTTGTCCGCCCACTTCCCCTGGTCCCGCCCTTTACCCCTTACTCCCTACCCCTCCCCC
AGCACCACTCCTAAGACGCGCACACGCTGCCTCGAGCAACCGAGTCAGCCGGAAGTCTTGCCGTAAAGCGTG
CTACGACCATCGTACTAGCGCCGGTTCCCTTGGAGACAAGCAACGCGTTCAAGATGGCGGCGCCGGCGGAGG
CGGAGGTGGCCGCGGGCTTCGCCGAGGCGGATGAAGCAGCGGAACTGACCCGCGCGCTAGGTCGTCTGTTA
CCGGGACTGGA 
>GXP_2963156(Hspa1b/rat) 
loc=GXL_187112|sym=Hspa1b|geneid=294254|acc=GXP_2963156|taxid=10116|spec=Rattus 
norvegicus|chr=20|ctg=NC_005119|str=(+)|start=3955107|end=3955707|len=601|tss=501|descr=
heat shock 70kD protein 1B (mapped)|comm=GXT_23117308/ENSRNOT00000049667/501/bronze 
GCCAAGCGTTATCCCTCCCGTTTTGAGAAACTTTCTGCGTCCGCCATCCTGTAGGAAGAATTTGTACACCTTAA
ACTCCCTCCCTGGTCTGATTCCCAAATGTCTCTCACCGCCCAGCACTTTCAGGAGCTGACCCTTCTCAGCTTCAC
ATACAGAGACCGCTACCTTGCGTCGCCATGGCAACACTGTCACAACCGGAACAAGCACTTCCTACCACCCCCC
GCCTCAGGAATCCAATCTGTCCAGCGAAGCCCAGATCCGTCTGGAGAGTTCTGGACAAGGGCGGTACCCTCA
ACATGGATTACTCATGGGAGGCGGAGAAGCTCTAACAGACCCGAAACTGCTGGAAGATTCCTGGCCCCAAGG
CCTCCTCCCGCTCGCTGATTGGCCCATGGGAGGGTGGGCGGGGCCGGAGGAGGCTCCTTAAAGGCGCAGGG
CGGCGCGCAGGACACCAGATTCCTCCTCCTAATCTGACAGAACCAGTTTCTGGTTCCACTCGCAGAGAAGCAG
AGAAGCGGAGCAAGCGGCGCGTTCCAGAACCTCGGGCAAGACCAGCCTCTCCCAGAGCATCCCCACCGCGAA
GCGCAACCTTCTCCAGAGC 
 
 
 
 
104 
 
>GXP_3994204(Heatr1/rat) loc=GXL_322134|sym=Heatr1|geneid=361262|acc=GXP_3994204 | 
taxid=10116|spec=Rattus norvegicus|chr=17|ctg=NC_005116|str=(-)|start=68655147| 
end=68655810|len=664|tss=504|descr=HEAT repeat containing 1|comm=GXT_25266975/ 
trans_NM_144835/504/silver 
GTGGAAGTTTCCCGTGAATGAACCATCCCTGCTACACACCCATAAAGCTCCAAAAGACGACTGCAGAAACTGA
ATCCCAAACATAAGCCTGAGGGCACATACAAGGAACCCAAAGAGGCGAGCTTAAGTACCAAGGACTGGAGG
GGGCGGGGCTCCGAAAGAGGCGAGTCTTATAGGCGACTTTCTGAAAAGGAACTCCAAGAAGGAGGGGCTAT
GGGCGTGGTTTAGAGGTTTCCGTGAGGGGTGGGGCTTAAAAGAGGGGCGAGGAATAAGTGTGGGGTTTGG
AAAGAGGTGCGGATGGAAGGCGGAGCTTAAAGGGATGCGCAAGCGGAGGGCGGGGCTTTGAGGGTCAAGC
ACGTGGAGGGGAAAGTGAGTGGGGAATTAAATGACTGGCTTGAAGAATAGGCGGAACTTAGTGTCAGGGA
GGCGGGGCTGTTGTAACGCATTTCCTACTAAGATGTCCCTTTTCTCTTGCCGTAGTTGGAAGCCGGAAGTTCCT
ATGAGGCGTGCTTTAGAGTTCCGGGACAGTGCCGGCACCATGTGGGAGCTCCTCTAAGAAGTTGTTAGCTGT
CGAATCCTGCTGATATTCCTAGTTCGGGGTGAGGAGGAACACGGTGCGGCTAGGCGCGATCGTGTCTTGGGA
CGGGAGGCCAGGGTGGGCCTT 
>GXP_2964569(Hspa4l/rat) loc=GXL_627335|sym=Hspa4l|geneid=294993| acc=GXP_2964569| 
taxid=10116|spec=Rattus norvegicus|chr=2|ctg=NC_005101| str=(+)|start=127697753| 
end=127699004|len=1252|tss=786|descr=heat shock protein 4-like|comm=GXT_24198951/ 
trans_XM_002808421/786/silver 
AGAACACAAGGAATTGAATGAGAAGGATCAGCAGATACATGAAGAACCAGATAAGGGTCAGCATATACATG
AAGAATTGAACAAGAAGGGTCAGCATATAAATGAAGAACTAGGTAAGAAGGGCCAGCAGATACACGAAGAA
CTAGGTAAAAGCCAGGAGATACATGAAGAACTGGACCCTAAGGAACGGGGGACAAAGGGGCTGGATAAGG
AAGAGCCGAGTTCGCGCTGGGATGTGCATGGGAAGGAGCGGGACCGCCAGACTTCGTAAGTATAAGCTAAA
ACTTCTTCAAGTGCACAAAGGCAGCACGCCGCCCCTGGCAGGCTTCTTTTCTGAAATTCCGTGGGCAAGCAGG
TCAGGGCCTAGAAAACCAGTTTTCATGGGGAAAGCACCGGAAAGTGACAGGTTGGGACCGGGCAGCAGCGG
GGTGGCTCTGAGAAGGGGACAGTGCGGGCACCGCACAATGGGCACCACCTCACAGAGGAGTTGCAGGAGG
AGCCTCAGCACTAGCCACAAGCGGGGGGCCCCTCGGGGCGGCGAGGCCGGCGGTGAGCTCCCAGGCCAAGG
CTCTCCTCCCGGACCGTGGGAGGATGCGGGCGGGCGGCCGGGGCGAGCGGTGCTGAGGAGAGCGACTCCG
AGGAGGGTGGCGGCGCTGACAGGGCGGCGCTTAGGAGAGCGTCCGCAGGCCACGGCTGCCTCAGCGTTGCT
CGGAGACAGCCTCACCTCCCCTCGCGCCTCGCGACCGCCGCCCCGCCCTGCCCTGCGGGTTCCCTCCCGCCCCC
ATCTTTCCAGCTCTTTCTCCAACCTGCCACTCCGCAGCGAGCCGTTGCCGAGCGCTGACGGGAGCGGCCGAGG
GCGAGGCCGCCGAGCCTCAGCCGACCGGTGGCTCGCGCCTCCCGGGGCCGAGCGCGCAGGCGCAGACCGCA
GTAACTGCCGGTTGGGGGCGGCGAACCGCAGTGGAGACTAAGCGGCGGGCCGGGCGGAGGCGGCGCGGCG
CAGGCGAGCGGCTCCACCTCCGCAATTCCGACGCCCTGCCCTAGATTTTCTGACAGAGAGTGGGTCCTCTCCTT
TGCTTCTCGCAGGAGTCGCAGCGCCCGCAGTGGGGACCCGCAGCGGGACGCTGTCCCCCGACCCGGAGCGGT
AGGCGGGATGTCGGTGGTGGGCATTGACCTCGGCTTCCTCAACTGCTACATCGCTGTGGCGAGGAGCGGCGG
CATCGAGACCATCGCCAACGAGTACAGCGACAGGTGC 
 
 
 
 
 
 
105 
 
>GXP_3418059(Hspa4l/rat) loc=GXL_627335|sym=Hspa4l|geneid=294993| acc=GXP_3418059| 
taxid=10116|spec=Rattus norvegicus|chr=2|ctg=NC_005101|str=(+)|start=127698574| end=12769 
9176|len=603|tss=501|descr=heat shock protein 4-like|comm=GXT_24680446/ 
trans_ENSMUST00000108086/501/silver 
GAGCCGTTGCCGAGCGCTGACGGGAGCGGCCGAGGGCGAGGCCGCCGAGCCTCAGCCGACCGGTGGCTCGC
GCCTCCCGGGGCCGAGCGCGCAGGCGCAGACCGCAGTAACTGCCGGTTGGGGGCGGCGAACCGCAGTGGA
GACTAAGCGGCGGGCCGGGCGGAGGCGGCGCGGCGCAGGCGAGCGGCTCCACCTCCGCAATTCCGACGCCC
TGCCCTAGATTTTCTGACAGAGAGTGGGTCCTCTCCTTTGCTTCTCGCAGGAGTCGCAGCGCCCGCAGTGGGG
ACCCGCAGCGGGACGCTGTCCCCCGACCCGGAGCGGTAGGCGGGATGTCGGTGGTGGGCATTGACCTCGGC
TTCCTCAACTGCTACATCGCTGTGGCGAGGAGCGGCGGCATCGAGACCATCGCCAACGAGTACAGCGACAGG
TGCACGCCGTAAGTGCCGCACGCCCCCTTTCCTGGGGTGGGGTCCGGGACGCCCCCCCCCGCCCGTGACAGG
TGCAGCGTCTTCAGCCCAGACGAGGAGGGCAGGGGCTCGCCAACTCTGCTTGCCGCAGAGGTCTCTGACCCT
AGGGCCTCTGCGTGGGGCTGCAGAAAAGCGC 
>GXP_862885(Hspa2/rat) loc=GXL_468860|sym=Hspa2|geneid=60460|acc=GXP_862885| 
taxid=10116|spec=Rattus norvegicus|chr=6|ctg=NC_005105|str=(+)| start=99000041| 
end=99000641|len=601|tss=501|descr=heat shock protein 2|comm=GXT_22198962/ 
NM_021863/501/silver 
GTCTCAGAAAGAATTTCGACCCCCGGGAGCCTTCGGGAGGCCAGCGCCCTTTCCGTGCTGCCTCTGCGCGCCC
CGCCCCGCGCCGCGCCCCAGCGCCACACTCTTCGGGTTCCGCGCTGTTCATTGGGCATCTGCCCCGCCAATCTA
AAAGATGTCAACGAATCACGCTTTATAAAAGGCAAAGAGAGAGGGGAAAGGGGGCTTTTCACGCTGGCTCCC
TTGGCGCGAGCTTAACGCCCCCAAGCGGCTGGAGGCACTGGGCGGGGCTCATTTGCATAACGGCCGCCCCTT
GGTCTCCCTGCTGGGGGCTGGAGTCCCGCTCTCACCCACCTAGATATCTGTTGGACCACCGGCTGGTCACTCC
GACCAGGCAAGCCTGTGGGATCGCTGGACGGGTTGGAGCGGGCGGGCCCGGGGACCGATTGGCTCTGAGA
GTTTCCAGAAGGCAGGGGGTGGGGTGGGAGGACGACTATAAGACGGAGAAGCCCAGCAGGGGGATCCGGG
AGACGCTAGTCGCGCTCGTGGAGAGCAGTGCGAAGCGACCGTTGGCTCGGGTCCCGGCTTGCCTCTCCTGAC
TCTTTCGTCCTAACGTTGCTTTGCC 
>GXP_1731603(Hsf4/rat) loc=GXL_736263|sym=Hsf4|geneid=291960| acc=GXP_1731603| 
taxid=10116|spec=Rattus norvegicus|chr=19|ctg=NC_005118|str=(+)| start=35085032| 
end=35085632|len=601|tss=501|descr=heat shock transcription factor 4|comm=GXT_23138720/ 
NM_001106177/501/silver;GXT_24179864/ENSRNOT00000020682/501/silver 
TTAATATTCCTGCGTCCTGTGATCTCTAGTCGGCTGTGAAAGGGAGGGCAGGAAATACACAAAGGCTGGAAG
GACAGTCCCACCGGACATTCAAGAAGGAGACCTCAAGGGCCTTTGTACTGTGACTGTGGGGGATCGGGATCC
GGGCACCCTATACCCCGAGACTGACCAGTTCCCTAGCCTTCTCGCAGACCGGGCAAGTGCAACTTCACCCACC
ACTCTATCTGCCCGCCCTTACCTAGGTTCCACTATGTCCACAGATGAACTAGTCCTTTCCAAGCCCACAGATGTT
TTCTCCCAAACAACACAGACAGAGAGGAACTTGAGAAGGATGAGACTCGAACGTGGGCTCGCCCACCCACAC
ACCTACGTTTCAGCCAGTCCTTTCTCTCTGCCCGTGGCTGGGCCGCTGTCCGAGCCCCGCCTCTAGGGTTCGCA
CGCGGCCCCCGCCTGACCCGGCGCCCAGGGGCGGAGTAGGGCGGGGCGGGCGGCAAACGCAGCACTTTCAC
GGCTTTGACAAGCCCGCAGCGGCCGGGCTGGAACGCTGAGCCCGGCCGAGACTGCGCCATGCAGGAAGCGC
CAGCTGCGCTGCCCACGGAGC 
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>GXP_3995149(Hsf4/rat) loc=GXL_736263|sym=Hsf4|geneid=291960|acc=GXP_3995149| 
taxid=10116|spec=Rattus norvegicus|chr=19|ctg=NC_005118|str=(+)|start=35085188| 
end=35086379|len=1192|tss=1091|descr=heat shock transcription factor 4|comm=GXT_25265261/ 
trans_ENST00000517729/1091/silver 
CCCCGAGACTGACCAGTTCCCTAGCCTTCTCGCAGACCGGGCAAGTGCAACTTCACCCACCACTCTATCTGCCC
GCCCTTACCTAGGTTCCACTATGTCCACAGATGAACTAGTCCTTTCCAAGCCCACAGATGTTTTCTCCCAAACAA
CACAGACAGAGAGGAACTTGAGAAGGATGAGACTCGAACGTGGGCTCGCCCACCCACACACCTACGTTTCAG
CCAGTCCTTTCTCTCTGCCCGTGGCTGGGCCGCTGTCCGAGCCCCGCCTCTAGGGTTCGCACGCGGCCCCCGCC
TGACCCGGCGCCCAGGGGCGGAGTAGGGCGGGGCGGGCGGCAAACGCAGCACTTTCACGGCTTTGACAAGC
CCGCAGCGGCCGGGCTGGAACGCTGAGCCCGGCCGAGACTGCGCCATGCAGGAAGCGCCAGCTGCGCTGCC
CACGGAGCCAGGCCCCAGCCCGGTACCTGCCTTCCTCGGCAAGCTATGGGCGCTGGTAGGCGACCCAGGCAC
CGACCACCTCATCCGCTGGAGCCCGGTGAGGGCTGGGGCCCCTCAACTCCCTCAGTGGTCCCCGGGATCCCTC
CAATGTCTGTGAACACCCATGTCCACCCAGCCCCCGCCTGGGTCTGGGCTGTGAGTACCTCAGTTCAGCTGTCC
AGAGTGGATCACGGTGGAAGGGGTGTGTGAGACAAGGATGAGGAGAATTAAGGGTCCTAGAGCCTACAGG
GACCTAGGTAGTTCTCACTTTACTTCATCTACCCAGGGAAAAAACAGGCCAAGAAAAGGGAAGAACTAGCTTC
GTCTTTGGCTCAGAGTCAGGTAGAGTCTGGGACGGGTCTGAGATGGACCCTGGGTTGGCGTGTGCTAATTCT
TTCTGAGAACTGCATATAGATCTAGTTAGGGATAGGAATTCTTCGTGGTTATGACAGGATAGGCTCTACATGA
TACAGACCTGGCCAAGTCCTACCTCCCAGCGAGGTACAAATCTGTACCCCACAGTGAGTGAGTATGGCCCAGT
CGTGAGTGGCACTCACTCACGGAGTCTGGTCCCCACCCGCTTGCGGATGGTTGTCGTTCGTTCTCGGTAGAGT
GGCACCAGCTTCCTCGTAAGTGATCAGAGCCGCTTCGCCAAGGAAGTACTGCCCCAGTATTTCAAGCACAGCA
ATATGGCGAGCTTTGTTCGTCAACTCAAC 
>GXP_278484(Hspe1/rat) loc=GXL_233373|sym=Hspe1|geneid=25462|acc=GXP_278484| 
taxid=10116|spec=Rattus norvegicus|chr=9|ctg=NC_005108|str=(+)|start=53894833| 
end=53895625|len=793|tss=501|descr=heat shock protein 1 (chaperonin 
10)|comm=GXT_21772313/ NM_012966/501/silver 
GCACGTGATGAAAGCAGTATGGCCCTACTGGGCCTGAACAAGTGAACCGAGCCTGCGGCGTCGCTGACAGAC
TTATCCCCCAGCCCTCCGTGCTCGGTCCGCGCTGCAAGCAGGCCCACGAGCACCGGGCCGCCGTGCACGCCGA
GGCCGCGTACCTGCGGGGCGGCGGCGGAAGAGCACGAGGCGAGGCAGGCCGTCTGCGGCGAGTGAGGGAC
CCAGCACTGGGCGCGCACCGCAATGAGCCCGAGTCCCCTCCCTCCCCGGCCCCGCCCCGCGGCCCCGCGTGCG
CGCGCGCGCGCGCCCCACTTCTCCCACGCCCCGGCCCTGCAATCTGCATGCGACGCGCGCGGCCCCGCCCTCC
TTACCTGAGCGGCCTCAGCCCCGTGGCCTCAGCACTCTCCCGCCGCCGTACACTGGTTCCTGGGCCGCGCTCG
GTTCTAGAACCTTCCGGAAGGCCCCGCGCTTTTCGTGGGTGAAAGGTCAAGTGGCGTCATTTCCGGGAGGGG
CTTGTTCTTTCACCTCAGCGGCCGACCTGGAAAAGCCTAGAAAGTGCTCCCCTTTTCTTCCGCCTCCGGCTACCC
GCATCGGCCGCCTGCGCGGAGTCCTGGCCACCAATCGGCGCGCGCGCTGGAGTGGCCGCCTTCTCTCACGCT
AAGGGGCTGAGTGCGCCTGCGCGCTGCGCTGTCTTTTCACGTGTCCTGAGCCGGCCCACGGGAGTCTCCTTGC
AGCAGGAGTCCGAGTGCAGAGTCCGGAGCTGCGGCGGCGTAAGTCATGGTGAGTGTCTCGTGGCTGG 
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>GXP_52220(Hsp90b1/rat) loc=GXL_42957|sym=Hsp90b1|geneid=362862|acc=GXP_52220| 
taxid=10116|spec=Rattus norvegicus|chr=7|ctg=NC_005106|str=(-)|start=23347425| 
end=23348025|len=601|tss=501|descr=heat shock protein 90, beta, member 1|comm=GXT_2310 
7638/ENSRNOT00000059555/501/silver;GXT_23485332/NM_001012197/501/silver;GXT_24170419
/ENSRNOT00000059554/501/silver 
AATTTCTCTTTTGCGAAAAGAAACGCCCAAAAGAAAGGTGACGGCGAACGTAGCGCTGAAAGGGCTCGTAAC
GTGACCCACGTCGTAGACGGGAAAAGGGTATAAACCACATTGTCTTGGCTACGGTTTCCCCTAGTCACGGAAC
AAACGTTCTCTAAGAGCCGGAAGTGGTTCCCCGGGACCTCTAGGAAAGGACAGACGTGCTATGCGCCTACAT
TCATTGGACGGTTTTCCTCAGAGACCAAGGCTTCCCAGGCCAAGGGGTGGCCCGGTGTGTGAGGGGCCCGCG
GAGCCATTTGATTGGAGAAAAGCTGCTGGACAAACCCAATCGAAAGGAGCCACGCTTCGGGCATCGGGCACC
GCACCTGGACAGTTCCGATTGGCGAGTTGCGGTCCCCCCCATGCGTCCCCATTGGGTGCAGAGAGTGCGTGG
TGAGGCACGATTGGTGGGTTCGTGTTTCCCGTCCCCCGCCCGCAAGCTGTGGGGTGAAAAGCGGCCCGACCT
GCGCGCGGTTTAGTGGGCGGACCGCGCTGCTGGAGGTGTGAGGACCTGATGTACTCCGGGTTGGGCGGGGT
GGAGGCGGCTCCTGCGACCGAAAAG 
>GXP_202074(Hsp90aa1, LOC499735, LOC691091/rat) loc=GXL_168670|sym=Hsp90aa1, 
LOC499735, LOC691091|geneid=299331, 499735, 691091|acc=GXP_202074| taxid=10116| 
spec=Rattus norvegicus|chr=6|ctg=NC_005105|str=(-)|start=135418994| end=135419647| 
len=654|tss=501,552|descr=heat shock protein 90, alpha (cytosolic), class A member 1; similar to 
heat shock protein 1, alpha; similar to heat shock protein 1, alpha|comm=GXT_21799309/ 
NM_175761/501/silver;GXT_25267617/trans_ENSMUST00000124156/552/silver 
CTACGTCCCCAATGGGAGCCCGAAGACAGGGGGATCTTCTCGCCTCAGACACCTAACGCGCCGCAGAGGGCA
CTGAGGTTCACACAGCAACGCAGCCTCACATGGGAACATCCCTTTCGCAGACCCCACCCCCACCCCCCGAGAA
GAGGAGCCCTAGAGTGCTCACATGGCGGCCTCTAGCGCATGCGCTGGTCACCTTGTCCGCGCTCCACGAGAG
GCGGCGCGCGCGCGGCCCGGGAAGGCGCCAGGCCCGCCGAGAATCCCGGACTGCGCATGTCCAGAGCACCT
GGCTGTGGAGGAGGGGCTCGCGTTCGTTCTCCGCGCGGGTTCTGCGCGCTCCTGGTGGAGGGGCGGGGCCC
GTCCAGTGCGCAGGCGCAGGCGCGCGGCCGAGGCGACGGTTGGGGAGGGTTCTTCCGGAAGGTTCGGGAG
GCTTCTGGAAAAAGCGCCGCGCGCTGGGCGGGCCCGCCTCTATATAAGGCAGGCGCGGGGGGCGGCGCGCC
AGTTGCTTCAGTGTCCCGGTGCGGTTAGTCACGTTTCGTGCGTGCTCATTCTGCCAAGGTGAGTGTCCTCGCA
GAGGGGCTTAGTGGGGGATTGGGGAGAGAGGTTGACGGATGTAGACGCGGCGGCGGGGTCGGGGCCGCC
ATCCGAGCTCCC 
>GXP_2972579(Hsp90aa1, LOC499735, LOC691091/rat) loc=GXL_168670|sym=Hsp90aa1, 
LOC499735, LOC691091|geneid=299331, 499735, 691091|acc=GXP_2972579| taxid=10116| 
spec=Rattus norvegicus|chr=6|ctg=NC_005105|str=(-)|start=135418406| end=135419006| 
len=601|tss=501|descr=heat shock protein 90, alpha (cytosolic), class A member 1; similar to heat 
shock protein 1, alpha; similar to heat shock protein 1, alpha|comm=GXT_24190764/ XR_085622/ 
501/silver;GXT_24190787/XR_007019/501/silver 
CATCCGAGCTCCCTCAGCCCGCAGAGGTGGGCGGCCATGCCTTCAGACCCTAGGCCCCAGGCGGCCGCTACG
CCCCAGGCCCAGGATGCGGTGATGGCCGCCGAGGAGGAGCGGCGGCGGAGGGTCGGGGGCGAGGCGAAC
GTTCGGCTCTGGCCTTTGCCTAGGCCTCCCCGGCTCTCGCCGGTGCTCCTGAGGCGCGGGCGGAGGAGGGAG
GCGCCATAGCGGCGGCTTGTGGGGGGAGGGTGGCCGTTAGGAACGGCGTGCGTGGAGCCGCTTGGGTCCG
AACGTCCTCCCGGAGGCGCGCACATGCGCCTCGTAATTACCGCATTCTGAAATGAGGTCATCCCTTTGTCATCC
ACCCCCCCCCTCGGCCTCTTCTATTCCGTCCCCGTCTCAGACCGAAATAGAGTTCCTAAGGAATTTCTATAGGA
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>GXP_2972579(Hsp90aa1, LOC499735, LOC691091/rat) loc=GXL_168670|sym=Hsp90aa1, 
LOC499735, LOC691091|geneid=299331, 499735, 691091|acc=GXP_2972579| taxid=10116| 
spec=Rattus norvegicus|chr=6|ctg=NC_005105|str=(-)|start=135418406| end=135419006| 
len=601|tss=501|descr=heat shock protein 90, alpha (cytosolic), class A member 1; similar to heat 
shock protein 1, alpha; similar to heat shock protein 1, alpha|comm=GXT_24190764/ XR_085622/ 
501/silver;GXT_24190787/XR_007019/501/silver 
CATCCGAGCTCCCTCAGCCCGCAGAGGTGGGCGGCCATGCCTTCAGACCCTAGGCCCCAGGCGGCCGCTACG
CCCCAGGCCCAGGATGCGGTGATGGCCGCCGAGGAGGAGCGGCGGCGGAGGGTCGGGGGCGAGGCGAAC
GTTCGGCTCTGGCCTTTGCCTAGGCCTCCCCGGCTCTCGCCGGTGCTCCTGAGGCGCGGGCGGAGGAGGGAG
GCGCCATAGCGGCGGCTTGTGGGGGGAGGGTGGCCGTTAGGAACGGCGTGCGTGGAGCCGCTTGGGTCCG
AACGTCCTCCCGGAGGCGCGCACATGCGCCTCGTAATTACCGCATTCTGAAATGAGGTCATCCCTTTGTCATCC
ACCCCCCCCCTCGGCCTCTTCTATTCCGTCCCCGTCTCAGACCGAAATAGAGTTCCTAAGGAATTTCTATAGGA
AAGGGGTAGGTAGGCATTAGGACGCCTGCAGACATTCTGTGAGGCTTTAACACCGTCCCGTGTTCCCAGATGC
CTGAGGAAACCCAGACCCAAGACCAACCAATGGAGGAAGAGGAGGTCGAAACCTTTGCCTTTCAGGCAGAAA
TTGCCCAGTTAATGTCCTTGATCAT 
>GXP_4005779(Hsp90aa1, LOC499735, LOC691091/rat) loc=GXL_168670|sym=Hsp90aa1, 
LOC499735, LOC691091|geneid=299331, 499735, 691091|acc=GXP_4005779|taxid=10116 
|spec=Rattus norvegicus|chr=6|ctg=NC_005105|str=(-)|start=135418680| end=135419280| 
len=601|tss=501|descr=heat shock protein 90, alpha (cytosolic), class A member 1; similar to heat 
shock protein 1, alpha; similar to heat shock protein 1, alpha|comm=GXT_25267618/ 
trans_ENSMUST00000149189/501/silver 
CGCAGGCGCAGGCGCGCGGCCGAGGCGACGGTTGGGGAGGGTTCTTCCGGAAGGTTCGGGAGGCTTCTGG
AAAAAGCGCCGCGCGCTGGGCGGGCCCGCCTCTATATAAGGCAGGCGCGGGGGGCGGCGCGCCAGTTGCTT
CAGTGTCCCGGTGCGGTTAGTCACGTTTCGTGCGTGCTCATTCTGCCAAGGTGAGTGTCCTCGCAGAGGGGCT
TAGTGGGGGATTGGGGAGAGAGGTTGACGGATGTAGACGCGGCGGCGGGGTCGGGGCCGCCATCCGAGCT
CCCTCAGCCCGCAGAGGTGGGCGGCCATGCCTTCAGACCCTAGGCCCCAGGCGGCCGCTACGCCCCAGGCCC
AGGATGCGGTGATGGCCGCCGAGGAGGAGCGGCGGCGGAGGGTCGGGGGCGAGGCGAACGTTCGGCTCTG
GCCTTTGCCTAGGCCTCCCCGGCTCTCGCCGGTGCTCCTGAGGCGCGGGCGGAGGAGGGAGGCGCCATAGC
GGCGGCTTGTGGGGGGAGGGTGGCCGTTAGGAACGGCGTGCGTGGAGCCGCTTGGGTCCGAACGTCCTCCC
GGAGGCGCGCACATGCGCCTCGTAATTACCGCA 
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>GXP_241620(Hsp90ab1/rat) loc=GXL_201364|sym=Hsp90ab1|geneid=301252| acc=GXP_241620| 
taxid=10116|spec=Rattus norvegicus|chr=9|ctg=NC_005108| str=(+)|start=11032807| 
end=11033596|len=790|tss=664,690|descr=heat shock protein 90 alpha (cytosolic), class B member 
1|comm=GXT_21772405/NM_001004082/690/silver;GXT_24183722/ENSRNOT00000026920/664/si
lver 
AGAAATCGAAGCACCGCCACTGCTGCTCCTTCCGCCACAGGCCGCCAAAGAGTCCCTGCTAGCCCAGGCCCGC
GCCCCTCCCCTCGGAGAAGCTGCTCCCCGCCTGCCGCTTCGCTGTACCGGGGAGGGTGGGGATCAGGGACTC
CTTAAAGTTGGACAACGAATTTCTTATCATCCTTTTCTCTCGATGTGCGATTTGTAGGGAACATTCTAGTAAGAT
CGGGTCTGAAAATGGCAGCCGAATTGGTCACCTCCGTTCTCTTTCAGAAGTCCCTTGAGGACTGGACTCTTGA
GGGTGGGAGCGCCTACATCGAATTTTCTGCGCGAGTCCGTGGGGTATTCGCCGCAGATACATCCCCTAATAGC
ATATGCATGCTCCCTGGCCATCTTGAGGGCTACATGTCCTACTCATGCAGAAATGAGGGTACCAAACGCTATT
GAATTGGCCTTGACTCGCAGCCCAGGCCCGGGGTCCCGCTCTTCCCCGCCCCCTCCCCGGTCTGCGAGCATGA
CGTCAAGGTGGGCGGGCGGTGGCAGGTGCGTGGCTGGCAGCCACTCCTTTAAGGCGGAGGGATCCAAGGGC
GGGGCTAGGGCTGTGCTTCGCCTTATATAGGGCGGTCGGGGGCGTTTGGGAGCTCTCTTGAGTCACCCCCGC
GCAGCCTAGGCTTGCCGTGCGAGTCGGACGTGGTCCGGGCCCACCCTGCTCTGTACTACTACTCGGCTTTCTC
GTCAAGGTAAGGCCGCGCTCTCCTGTACTTGGCGGCTCCGTGGGTCTTCTTCCTGGGGTCTC 
>GXP_1727035(Ahsa2/rat) loc=GXL_735349|sym=Ahsa2|geneid=305577|acc=GXP_1727035| 
taxid=10116|spec=Rattus norvegicus|chr=14|ctg=NC_005113|str=(-)|start=104435411| 
end=104436011|len=601|tss=501|descr=AHA1, activator of heat shock protein ATPase homolog 2 
(yeast)|comm=GXT_23136523/NM_001107241/501/silver;GXT_24174123/ENSRNOT00000056855/
501/silver;GXT_24174124/ENSRNOT00000007297/501/silver 
GTTCCTTCAGTAACCCCTCGACCAGCTCTGCTGAGGAACCTGCGCAGCTCACTAGCTCGTGGCCCAGGGACCT
CAGAAAAGGGACAGCGGGCTCTCGTAGGAGCCCTGGGCGAAGTCTAGGCCAGAAGTCGAAGCCCTAGGCCA
GAAGCCCCGCCGGTCGACAGGAACCAGCAGCAGGAACCAGGCGGCTCAGGGGATACAAAGCGGAGGATGG
AGCCAGGGCGGAGTCTTAAGGACTGGGGACCCGGCGAAGTCGGGGGAGGAGCCTAGCAGAAGACGCCGCC
GGGAGGTGCCGCATAGGGCGGGGTCTTAGGGCCGAGAGGCGGGGCGAAGTCCGGGTGGGGGAGGATCCC
GGCAGAGGGCGGTGCCGGGAGGTGTGGCATATTGGGGGCGTGACGGGGTCCGCAGCAGAGTGGATGTGGG
GCGGAGCGGGCTGCGGGGAGCGGGCAGCGGGGCGGGGCAGGCTGCGGCCGGGCCGGCCCGGGGCGGGG
ACTTCTGGCACTTTCTGGGAGCTGCGGGCGTGCGGCTCACAGACCTTCTGGCCGGAAACCCGCGCGCTCCCGC
TGCCAGGGCCCTCGTCGTCAGCGCCGCCATGGCCAAG 
>GXP_853081(Pdap1/rat) loc=GXL_468142|sym=Pdap1|geneid=64527| acc=GXP_853081| 
taxid=10116|spec=Rattus norvegicus|chr=12|ctg=NC_005111| str=(+)|start=9784230| 
end=9784844|len=615|tss=515|descr=PDGFA associated protein 1|comm=GXT_22199040/ 
NM_022595/515/silver 
AGCCTCTGCTGCTTAAGCAGCTCAGACAGCCCTCCTGGCCGTAACTATTGCCAAAAGGTACAATATTCAAGAA
CGGAGCAGGTAAACACTCACCGGAAACTCAAGCACCTAGGAACGCCGCTTCTTTATTGACGGCTTCCGCTCCG
GTGAGAAACTCTTCAGAATAAGGCCCTCGCGGGGCCCCGCCCACCTCGCCCAGAGATTGCGTCATCTTAGGTG
TCCGTAGCGCTGCCTTTGTAGAATTTCGGAAAACGTACGGCCCTTTCCCTCTCACTTCCTGTGGGGGTGGCCCG
CACGGCTACGTGTCTCCTCAGACAGGGACACCGGGGAACGCAGATTCCTGGCTGCACATATTCTGGCCAGGA
ATTCAGGCACCTCTTAAGACAGCCCGACCTCGGTGAGGTCCCAGTTCCTCGCAGCAGCCGCGGCGGCGGCGG
CGCGCGGAGAGGAACCAGGCCGGGCGGAAGAAGTCTATCCCAAGGTATTTCCGGTTCCGGTGTCAGTTCGAG
 
 
 
 
 
110 
 
>GXP_853081(Pdap1/rat) loc=GXL_468142|sym=Pdap1|geneid=64527| acc=GXP_853081| 
taxid=10116|spec=Rattus norvegicus|chr=12|ctg=NC_005111| str=(+)|start=9784230| 
end=9784844|len=615|tss=515|descr=PDGFA associated protein 1|comm=GXT_22199040/ 
NM_022595/515/silver 
AGCCTCTGCTGCTTAAGCAGCTCAGACAGCCCTCCTGGCCGTAACTATTGCCAAAAGGTACAATATTCAAGAA
CGGAGCAGGTAAACACTCACCGGAAACTCAAGCACCTAGGAACGCCGCTTCTTTATTGACGGCTTCCGCTCCG
GTGAGAAACTCTTCAGAATAAGGCCCTCGCGGGGCCCCGCCCACCTCGCCCAGAGATTGCGTCATCTTAGGTG
TCCGTAGCGCTGCCTTTGTAGAATTTCGGAAAACGTACGGCCCTTTCCCTCTCACTTCCTGTGGGGGTGGCCCG
CACGGCTACGTGTCTCCTCAGACAGGGACACCGGGGAACGCAGATTCCTGGCTGCACATATTCTGGCCAGGA
ATTCAGGCACCTCTTAAGACAGCCCGACCTCGGTGAGGTCCCAGTTCCTCGCAGCAGCCGCGGCGGCGGCGG
CGCGCGGAGAGGAACCAGGCCGGGCGGAAGAAGTCTATCCCAAGGTATTTCCGGTTCCGGTGTCAGTTCGAG
GCGCCGCCGCCGCTGCAGCCGCCGGAGCCGAGATGCCTAAAGGAGGTGAGGGGGTGGGCGCGCGTGATTC
GCGTGGCTTCTCTAGTGGCGGCCGTACGCCGACTGC 
>GXP_514212(Dnajb6/rat) loc=GXL_324763|sym=Dnajb6|geneid=362293|acc=GXP_514212| 
taxid=10116|spec=Rattus norvegicus|chr=4|ctg=NC_005103|str=(-)|start=796137| end=796737| 
len=601|tss=501|descr=DnaJ (Hsp40) homolog, subfamily B, member 6|comm=GXT_21925644/ 
NM_001013209/501/silver;GXT_24169497/ENSRNOT00000014194/501/silver 
ATTCGGCACTCCATGTAAGTAATGATGGGGCCTCTCACGGTTCAAGTAAGATCAGGGCTGGGGACGGGGCAC
TGAGGAGGATCTAAGTCGGGACCACAGCTCTCAACGTCCATTGGGAGTGTGAGTCATATTATGCTAGCAGCTC
GTTATCTCAGAATCCACAGTCAGAGGCTGTGAGCGTCCTTCCTCCCAGCCTGCTTCCGGCAAACGCAGGATTG
TCTACAGGTCGCCTCAGGCTTTAGAGTCCTCCAGGCTCAGGGCTTGCGAAAGGTGGCGGTTTCCCACTCTATT
CAGTCGCCTATATAAACCCTCTAGAGTTCCACCATGCTCAGCTCCGAGAATCTTCAGGTCTGGGAGACGCGCG
CTATCGGATCCGACGACCAAGGAAGCTGCTGTGCACGCTAGCTTCAGGGCCGGGCGGAAGTCGACGTCGCCG
CGCCGCCACCGCGTGACGCACTTCCTGTTTGTTGTTGGAGAAAAGGAGAGAAAGGAAAGCGCGAGGAGACG
CCGCCACCGCCACCAGCGCACTGTGCCAGAGCCGCGAGGAGACCGGCCGCCTGACTTCCCCCCTCGCTGGCC
GCCGCGTCCTCGGTGAGGGTCC 
>GXP_1742(Dnaja1/rat) loc=GXL_1468|sym=Dnaja1|geneid=65028|acc=GXP_1742| 
taxid=10116|spec=Rattus norvegicus|chr=5|ctg=NC_005104|str=(+)| start=58100294| 
end=58100894|len=601|tss=501|descr=DnaJ (Hsp40) homolog, subfamily A, member 
1|comm=GXT_21769964/NM_022934/501/silver 
CAGGTTCTGTCCGCCCAAGTCAGAGCCAGAAGGATCTGAAGCCTGGGCTCATCCAAAAAGCTGTGACAGGAG
TGCGCTTGGGTGAAACCACCGGATCCAAAGCCTGCAAGGCTAGTCTAGGGACTAGGCCCGCCTTGCTCAGCA
TTTCTTGCCCGCAAGGCTCAGAGCTAAGGAGCTGCAGAAAATTAGACTCCGGTGAGGTTAGGATCCCTTCTGC
ACAGCGCCTGAAGCACTCGTCCCCGGCTTACGGCTCTGGGACATGACCTCTCCACCTCAAGACTTCCGCCCTCT
GGTACCTCGCATAAAGAAAAAGCCTCTAGAAGATTCTACAAGGATCGGGAACCCGGGCCTGAGTCCACCCCC
ACAAGGCCCTTGGGCGCAGCCACTCTCCGCCCCCGCGCCGTTGCCCAGGTAACCGAGGGGCGGTGGCAGAAG
CGAGGGGCGGGACTTCCGGCAAGTGACGCGCCCGGGCTCCGCTACAAAAGAGGTCGGCTGCGGCGGGCCG
GGCGGAACTTTCCAGAACGCTCGGTGGGTGGTAGAGGAGCAGCGTCTGGCCGAGCTGCGCTGTGCTACGCTC
CTCTTTCCGCTCTCCGGCGCCGGC  
 
 
 
 
